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Abstract 
 
Part I: Total Synthesis of Variecolortides A–C 
The variecolortides are structurally intriguing, fungal natural products that present a unique 
merger of three major streams of biosynthesis. They can be traced back to other known 
natural products, namely the viocristins and echinulins, and we wanted to prove if they could 
somehow come together to form the variecolortides. Thus, these natural products were 
prepared in short sequences and their critical linkage was subsequently investigated. It was 
found that an unprecedented hetero-Diels-Alder reaction effected this linkage and furnished 
the central spirocyclic core of the variecolortides. Ultimately, a highly convergent route to all 
three variecolortides (A–C) was developed. The natural products were each efficiently 
synthesized as racemates in seven steps or less (longest linear sequence), largely avoiding 
protecting group chemistry.  
Part II: Towards the Total Synthesis of Naphthomycin K and Divergolides C and D 
Ansamycins are an important class of natural products that often show potent antibacterial 
and antiviral activities. We have engaged in the total syntheses of several new 
aminonaphthoquinone ansamycins, including naphthomycin K and divergolides C and D. A 
unified approach to their naphthoquinone core was targeted and led to the development of a 
novel, cyano-substituted Danishefsky-type diene. The latter was used in the synthesis of 
cyano-substituted naphthoquinones, naphthalenes and other highly functionalized small 
molecules. Since the cyano-substituted naphthoquinones could not be further elaborated into 
the desired natural products, alternatively substituted bromonaphthalenes were instead 
synthesized over short sequences. In addition, several strategies towards the synthesis of an 
ansa chain fragment of divergolides C and D were developed.  
Part III: Synthesis of Photochromic Open-Channel Blockers 
Optical control of transmembrane ion channel function with high temporal and spatial 
precision opens the door for a better understanding of neuronal circuits and pharmacological 
associated questions. Several red-shifted derivatives of QAQ (quaternary ammonium-
azobenzene-quaternary ammonium), a powerful doubly charged photochromic blocker, have 
been synthesized. They allow for remote control of Kv and Nav channel conductance with 
light and offer the opportunity to reversibly silence neuronal activity.  
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Part I: Total Synthesis of Variecolortides A–C 
1 Introduction 
Nature remains a major source of inspiration for synthetic chemists, not only in terms of the 
structures it produces, but also with respect to the strategies it uses for their construction. 
These have been mimicked with remarkable success in the laboratory, yielding many elegant 
and efficient syntheses of natural products.1 Many of these “biomimetic” syntheses 
incorporate reaction cascades, the role of which in the origin of natural products has been 
increasingly recognized.2 Cascade reactions can create several stereocenters in a single step, 
which allows for the spontaneous construction of very complex chiral molecules from achiral 
precursors. In the absence of an asymmetric environment (e.g. an enzyme pocket) however, 
there is no reason why one enantiomer should be preferred over the other. Hence, complex 
natural products, that have been isolated in racemic form (Figure 1) can be suspected to arise 
through cycloadditions or cascade reactions in a more or less spontaneous fashion and thus 
are prime candidates for biomimetic total synthesis. 
 
Figure 1. A selection of racemic natural products that have been made through biomimetic cascade reactions. 
1.1 Isolation and Structure  
Shortly after we had published our biomimetic synthesis of the potent indolamine-2,3-
dioxygenase (IDO) inhibitors exiguamines A (1.1) and B (1.2),3 the variecolortides A–C (1.3–
                                                
1 Razzak, M.; De Brabander, J. K. Nat. Chem. Biol. 2011, 7, 865–875. 
2 Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Angew. Chem. Int. Ed. 2006, 45, 7134–7186. 
3 Volgraf, M.; Lumb, J.-P.; Brastianos, H. C.; Carr, G.; Chung, M. K. W.; Münzel, M.; Mauk, A. G.; Andersen, 
R. J.; Trauner, D. Nat. Chem. Biol. 2008, 4, 535–537. 
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1.5) attracted our attention. These alkaloids, which occur as racemates in nature, were isolated 
from the halotolerant fungal strain Aspergillus variecolor B-17 and their structures and 
biological activities were reported by Wang et al. in 2007.4 We were particularly captivated 
by the intriguing structure of the variecolortides. They each feature a pyrano-anthrone moiety 
which contains four conjugated rings and is connected to a central diketopiperazine moiety 
that forms a central spirocyclic N,O-acetal. A similar structural motif can also be found in the 
exiguamines. The central diketopiperazine moiety is further connected to a reversely 
prenylated indole, which additionally possesses either a hydrogen or a prenyl group at C22.  
 
Figure 2. Structures of exiguamines A (1.1) and B (1.2) and variecolortides A–C (1.3–1.5). 
In terms of their biological activity, the variecolortides have been found to display cytotoxic 
activity against K-562 human leukemia cells and weak radical scavenging activity against the 
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical. However, further investigations are necessary 
to explore the pharmacological relevance of these fungal natural products. 
1.2 Proposed Biosynthesis 
Not only did we find their unique connectivity particularly appealing, but we were also drawn 
to the fact that each of the substructures present in the variecolortides stem from a different 
biosynthetic pathway. As such, these alkaloids present an intriguing union of three different 
biosynthesis pathways: the type II polyketide pathway for the northern anthraquinone moiety, 
the shikimic acid pathway for the aromatic amino acid tryptophan and the terpenoid pathway 
for the prenyl- and reverse-prenyl side chains (Scheme 1). To the best of our knowledge, this 
is the first example of such a combination of biosynthetic pathways reported to date. 
                                                
4 Wang, W.-L.; Zhu, T.-J.; Tao, H.-W.; Lu, Z.-Y.; Fang, Y.-C.; Gu, Q.-Q.; Zhu, W.-M. Chem. Biodiversity 2007, 
4, 2913–2919. 
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Scheme 1. Biosynthetic analysis of the variecolortides.  
A retro-biosynthetic analysis of the variecolortides suggests that they may derive from 
known, albeit less complex natural products (Scheme 1). Specifically, we think that the 
northern part of the variecolortides can be traced back to hydroxyviocristin (1.6) and 
viocristin (1.7) respectively. These naturally occurring 1,4-anthraquinones have been isolated 
from Aspergillus cristatus by Laatsch and coworkers in 1982.5 Their postulated biosynthesis 
follows the well-studied polyketide pathway.6 As depicted in Scheme 2, octaketide 1.10, 
derived from acetyl- and malonyl-CoA, would be transformed into atrochrysone carboxylic 
acid (1.11) through a series of steps involving aldol reactions, dehydration, enolization and 
hydrolysis from the enzyme. Decarboxylation and subsequent dehydration of 1.11 would lead 
to emodin anthrone (1.12), which upon oxidation and tautomerization forms 
hydroxyviocristin (1.6). Selective methylation by S-Adenosylmethionine (SAM) finally 
would afford viocristin (1.7).  
                                                
5 Laatsch, H.; Anke, H. Liebigs Ann. Chem. 1982, 2189–2215.  
6 Dewick, P. M. Medicinal Natural Products: A Biosynthetic Approach, 3rd ed.; John Wiley & Sons Ltd: 
Chichester, 2009. 
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Scheme 2. Proposed polyketide pathway for the biosynthesis of hydroxyviocristin (1.6) and viocristin (1.7). 
The southern part of the variecolortides may arise from neoechinulin B (1.8)7 and isoechinulin 
B (1.9)8. These natural products were isolated independently from each other in the 1970s 
from the mycelia of Aspergillus ruber and Aspergillus amstelodami respectively. In 2007, 
Wang et al. reported their reisolation together with several other analogues from the broth of 
the halotolerant fungus Aspergillus variecolor.9 In addition, Wang and coworkers also 
proposed a mixed amino acid-mevalonic acid pathway for the biosynthesis of these alkaloids 
(depicted in Scheme 3 for neoechinulin B (1.8) and isoechinulin B (1.9)). Starting from the 
amino acids tryptophan and alanine, cyclo(Trp-Ala) (1.13) would be formed in the first step 
by intermolecular cyclization. Further reaction with mevalonic acid would give preechinulin 
(1.14).10, which in turn could be dehydrogenated to give neoechinulin A (1.15). Proceeding 
from this natural product, one more dehydrogenation step would lead to the formation of 
neoechinulin B (1.8), which could be reversely-prenylated by reaction with mevalonic acid to 
form isoechinulin B (1.9).  
                                                
7 (a) Dossena, A.; Marchelli, R.; Pochini, A. J. Chem. Soc., Chem. Comm. 1974, 771–772; (b) Marchelli, R.; 
Dossena, A.; Pochini, A.; Dradi, E. J. Chem. Soc., Perkin Trans. 1, 1977, 713–717.  
8 Nagasawa, H.; Isogai, A.; Suzuki, A.; Tamura, S. Tetrahedron Lett. 1976, 19, 1601–1604.  
9 Wang, W.-L.; Lu, Z.-Y.; Tao, H.-W.; Zhu, T.-J.; Fang, Y.-C.; Gu, Q.-Q.; Zhu, W.-M. J. Nat. Prod. 2007, 70, 
1558–1564.  
10 Hamasaki, T.; Nagayama, K.; Hatsuda, Y. Agric. Biol. Chem. 1976, 40, 203–205. 
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Scheme 3. Postulated biosynthetic pathway to neoechinulin B (1.8) and isoechinulin B (1.9). 
We were fascinated by the question, if these natural products could indeed come together to 
form the variecolortides, prompting us to explore their biomimetic synthesis. 
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2 Results 
2.1 Published Results 
2.1.1 Concise Total Syntheses of Variecolortides A and B through an Unusual 
Hetero-Diels-Alder Reaction 
Publication: Kuttruff, C. A.; Zipse, H.; Trauner, D. Angew. Chem. Int. Ed. 2011, 50, 1402–
1405 and Kuttruff, C. A.; Zipse, H.; Trauner, D. Angew. Chem. 2011, 123, 1438–1441. 
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2.1.2 Evolution of a Synthetic Strategy for the Variecolortides 
Publication: Kuttruff, C. A.; Mayer, P.; Trauner, D. Eur. J. Org. Chem. 2012, Article ASAP. 
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Part II: Towards the Total Synthesis of 
Naphthomycin K and Divergolides C and D 
1 Towards the Total Synthesis of Naphthomycin K 
1.1 Introduction and Background 
1.1.1 Ansamycins Antibiotics 
Polyketides are natural products with great structural diversity and a wide range of biological 
activities.1 The immunosuppressant rapamycin,2 the antibiotic erythro-mycin A,3 or the 
cytostatic drug doxorubicin4 represent only a small selection of polyketides that play a crucial 
role in today´s medicine (Figure 1).  
 
Figure 1. A selection of biologically active polyketide natural products.  
One important class of polyketides that our group has become increasingly interested in are 
the so called ansamycins. These macrocyclic lactam antibiotics are characterized by their 
"basket-like" structures consisting of an aromatic moiety that is flanked at non-adjacent 
positions by an aliphatic chain, like a handle or "ansa" (lat. grip).5 Lüttringhaus was the first 
who called this aliphatic moiety of varying length an ansa chain.6 The term "ansamycins" was 
                                                
1 Dewick, P. M. Medicinal Natural Products: A Biosynthetic Approach, 3rd ed.; John Wiley & Sons Ltd: 
Chichester, 2009. 
2 (a) Vézina, C.; Kudelski, A.; Sehgal, S. N. J. Antibiot. 1975, 28, 721–726; (b) Sehgal, S. N.; Baker, H.; Vézina, 
C. J. Antibiot. 1975, 28, 727–732. 
3 McGuire, J. M.; Bunch, R. L.; Anderson, R. C.; Boaz, H. E.; Flyn, E. H.; Powell, H. M.; Smith, J. W. Antibiot. 
Chemother. 1952, 2, 281–283.  
4 Di Marco, A.; Gaetani, M.; Scarpinato B. Cancer Chemother. Rep. 1969, 53, 33–37. 
5 Wrona, I. E.; Agouridas, V.; Panek, J. S. C. R. Chimie 2008, 11, 1483–1522. 
6 Lüttringhaus, A.; Gralheer, H. Liebigs Ann. Chem. 1947, 557, 112–120. 
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later termed by Prelog and Oppolzer.7 As depicted in Figure 2, the ansamycins can be divided 
into two groups based on their aromatic nucleus. The naphthalenoid or naphthalenic 
ansamycins (e.g. rifamycin, streptovaricin, naphthomycin) possess a 1,4-naphthoquinone or 
1,4-hydroxy-naphthalene moiety as the chromophore. The benzenoid or benzenic ansamycins 
including e.g. geldanamycin, maytansine or herbimycin were isolated later than the 
corresponding naphthalenes and contain a 1,4-quinone or 1,4-hydroquinone unit. In terms of 
their biological activity, the naphthalenic ansamycins mostly exhibit strong antimicrobial 
activities,8 whereas benzenic ansamycins have shown promise as potential antitumor agents.9  
 
Figure 2. Classification of ansamycins based on their aromatic nucleus (illustrated in blue and green). Rifamycin 
B (a naphthalenic ansamycin) and geldanamycin (a benzenic ansamycin) are two examples of these groups of 
ansamycins. 
Amongst the vast number of ansamycins that have been reported to date, we are particularly 
interested in naphthomycins A (2.1) and K (2.2), divergolides C (2.3) and D (2.4) and 
ansalactam (2.5), all of which are naphthalenic ansamycins (Figure 3). Due to their intriguing 
structures and interesting biological activities, we have engaged in their total syntheses. The 
major goal of the presented work in this chapter was the synthesis of a naphthalene core, 
which could be utilized in the synthesis of all of the targeted ansamycins.  
In the following sections, a short background summary as well as the results of our recent 
efforts towards these ansamycins will be presented.  
                                                
7 Prelog, V.; Oppolzer, W. Helv. Chim. Acta 1973, 56, 2279–2287. 
8 Wehrli, W., Staehlin, M. Bacteriol. Rev. 1971, 35, 290–309.  
9 Cragg, G. M.; Kingston, D. G. I.; Newman, D. J. Anticancer Agents from Natural Products, 2nd ed.; Taylor & 
Francis: Boca Raton, 2012.  
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Figure 3. Naphthalenic ansamycins that were targeted as part of this Ph.D. thesis. 
1.1.2 Naphthomycins A-J 
The naphthomycins are a family of natural products that belong to the naphthalenoid 
ansamycins with C23 ansa chains. Their first member, naphthomycin A (2.1), was isolated in 
1969 as a yellow pigment from the cultured broth of strain Tü 105 of Streptomyces collinus 
by Balerna et al.10 It took 15 years until its absolute configuration could be elucidated, mainly 
by chemical degradation and X-ray structural analysis of a methylated derivative, 25-O-
methylnaphthomycin A iminomethyl ether (2.6) (Figure 4).11  
 
Figure 4. Structural drawing of naphthomycin A (2.1) and X-ray structure of its derivative 25-O-methyl-
naphthomycin A iminomethyl ether (2.6).  
As shown in Figure 5, further members of this family were subsequently isolated and 
reported. Naphthomycins B (2.9) and C (2.10) were isolated in 1983 from S. collinus, strain 
                                                
10 Balerna, M.; Keller-Schierlein, W.; Martius, C.; Wolf, H.; Zähner, H. Arch. Mikrobiol. 1969, 65, 303–317. 
11 Keller-Schierlein, W.; Meyer, M.; Cellai, L.; Cerrini, S.; Lamba, D.; Segre, A.; Fedeli, W.; Brufani, M. J. 
Antibiot. 1984, 37, 1357–1361. 
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Tü 353 and Tü 1892 respectively.12 They differ from naphthomycin A not only in the 
configuration of their C4-C5 double bond, but also lack a methyl group at C2 (Figure 5). 
Three years later, the isolation of four other naphthomycins, namely naphthomycins D (2.7), 
E (2.8), F (2.11) and G (2.12), from the strain Tü 2357 of Streptomyces aurantiogriseus, was 
reported by the same group.13 Distinguishing features of naphthomycins D (2.7) and E (2.8) 
are an OH and H substituent at C30 instead of a Cl substituent present in naphthomycin A 
(2.1). Naphthomycins F (2.11) and G (2.12) on the other hand, possess an N-acetylcysteine 
residue linked to C30 of the naphthoquinoid moiety by a thioether group. Whilst 
naphthomycin F (2.11) displays some biological activity against gram-positive bacteria and 
fungi, naphthomycins D (2.7), E (2.8) and G (2.12) were found to be inactive against 
microorganisms. The structure of naphthomycin H (2.13)14 was published by Mukhopadhyay 
et al. in 1985 and finally, Hooper and coworkers reported the isolation of naphthomycins I 
(2.12, identical to napthomycin G) and J (2.14).15  
 
Figure 5. Structures of naphthomycins A–J. Differences from the parent naphthomycin A (2.1) are highlighted in 
red. 
                                                
12 Keller-Schierlein, W.; Meyer, M.; Zeeck, A.; Damberg, M.; Machinek, R.; Zähner, H.; Lazar, G. J. Antibiot. 
1983, 36, 484–492. 
13 Meyer, M.; Keller-Schierlein, W.; Megahed, S.; Zähner, H.; Segre, A. Helv. Chim. Acta 1986, 69, 1356–1364. 
14 Mukhopadhyay, T.; Franco, C. M. M.; Reddy, G. C. S.; Ganguli, B. N.; Fehlhaber, H. W.; J. Antibiot. 1985, 
38, 948–951. 
15 Hooper, A. M.; Rickards, R. W. J. Antibiot. 1998, 51, 845–851. 
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1.1.3 Naphthomycin K 
The newest member of the naphthomycin family is naphthomycin K (2.2), which was 
reported in 2007 by Lu and Shen.16 Naphthomycin K (2.2) was isolated together with 
naphthomycins A (2.1) and E (2.8) from the commercial strain Streptomyces sp. CS of the 
medicinal plant Maytenus hookeri (Figure 6). Its structure was elucidated by the analysis of 
NMR and MS data. Interestingly, whilst naphthomycins are usually known for their 
antibacterial and antifungal activities, 2.2 displayed cytotoxic activity against P388 and A-549 
cell lines.  
 
Figure 6. Structure and plant source17 of the natural product naphthomycin K (2.2).  
In addition to its interesting biological activity, we were particularly attracted by the unusual 
structure of naphthomycin K (2.2). It features nine stereogenic centers, a highly 
functionalized ansa chain and an unprecedented naphthoquinone core that contains a 
substituted oxa-aza-bicyclo[3.3.1]-nonenone ring system. What we found particularly 
interesting is the fact that the published structure of naphthomycin K (2.15) differs from the 
structures of naphthomycin A–J in two important aspects (Figure 7). In the structure of 
naphthomycin K (2.15) assigned by Lu and Shen, the absolute configuration of the methyl 
group at C8 is (R). Furthermore, the double bond geometry between C21 and C22 is claimed 
to be (Z). However, all other naphthomycins that have been reported to date share a methyl 
group at C8 that has a (S)-configuration and a (E) double bond between C21 and C22. We 
thus believe that the reported structure might be misassigned and herein propose a slightly 
different structure of naphthomycin K (2.2), which we wish to prove by total synthesis. 
                                                
16 Lu, C.; Shen, Y. J. Antibiot. 2007, 60, 649–653. 
17 Source of picture: http://tupian.hudong.com 
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Figure 7. A. Structure of naphthomycin K (2.15) assigned by Lu and Shen.16 B. Structure of naphthomyin K (2.2) 
proposed by our group.  
1.1.4 Biosynthesis of the Naphthomycins 
As depicted in Scheme 1, we believe that naphthomycin K (2.2) is formed from 
naphthomycin A (2.1) via hetero-Diels-Alder reaction between the carbonyl group at C28 and 
the diene between C2 and C5. Naphthomycin A (2.1) in turn, could be formed from 
naphthomycin E (2.8) by chlorination at C30. Our assumption that 2.1 and 2.8 are 
biosynthetic precursors of naphthomycin K (2.2) is supported by the fact that naphthomycins 
A (2.1) and E (2.8) were isolated together with naphthomycin K (2.2) from the same 
organism.  
 
Scheme 1. Proposed formation of naphthomycin K (2.2) from its biosynthetic precursors naphthomycin A (2.1) 
and E (2.8).  
The biosynthesis of naphthomycin A (2.1) was studied by Lee and coworkers and published 
in 1994.18 It was shown by 13C-labeling experiments and NMR-analysis that 2.1 is assembled 
via the polyketide pathway and that its structure can be traced back to 3-amino-5-
hydroxybenzoic acid (AHBA, 2.16) as the starter unit (mC7N unit), seven propionate (methyl-
malonyl-CoA) and six acetate (malonyl-CoA) chain extension units (Scheme 2).  
                                                
18 Lee, J. P.; Tsao, S.-W.; Chang, C.-J.; He, X.-G.; Floss, H. G. Can. J. Chem. 1994, 72, 182–187. 
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Scheme 2. Biosynthetic analysis of naphthomycin A (2.1). It is derived from one mC7N, six acetate and seven 
propionate units.  
AHBA is synthesized via the aminoshikimate pathway from 5-deoxy-5-amino-3-
dehydroshikimic acid (amino-DHS) by the action of AHBA synthase.19  
Recently, Wu et al. reported the cloning and functional analysis of the naphthomycin 
biosynthetic gene cluster in Streptomyces sp. CS.20 Deduced from their results, the 
biosynthesis of naphthomycin A is initiated by a AHBA starter unit which is extended to a 
tetraketide by incorporation of two methyl-malonyl-CoA and one malonyl-CoA unit (Figure 
8).  
 
Figure 8. Putative biosynthetic pathway for naphthomycin A. ADE, carboxylic acid: ACP ligase (loading domain); 
KS, β-ketoacyl-ACP synthase; DH, β-hydroxyacyl-thioester dehydratase; KR, β-ketoacyl-ACP reductase; ER, 
enoyl, reductase. The putative intermediates in chain-extension cycles and the nat genes involved in the various 
biosynthetic steps are indicated. The redundant domains are labeled with *. R, methyl or H.20 Source: [20] 
                                                
19 (a) Kim, C.-G.; Kirschning, A.; Bergon, P.; Ahn, Y.; Wang, J. J.; Shibuya, M.; Floss, H. G. J. Am. Chem. Soc. 
1992, 114, 4941–4943; (b) Kim, C.-G.; Kirschning, A.; Bergon, P.; Zhou, P.; Su, E.; Sauerbrei, B.; Ning, S.; 
Ahn, Y.; Breuer, M.; Leistner, E.; Floss, H. G. J. Am. Chem. Soc. 1996, 118, 7486–7491; (c) Kim. C.-G.; Yu, T.-
W.; Fryhle, C. B.; Handa, S.; Floss, H. G. 1998, 273, 6030–6040.  
20 Wu, Y.; Kang, Q.; Shen, Y.; Su, W.; Bai, L. Mol. BioSyst. 2011, 7, 2459–2469. 
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Nat2 mediated oxidation of this tetraketide intermediate followed by cyclization gives rise to 
the naphthalene ring. This intermediate is further extended with five methyl-malonyl-CoA 
and five malonyl-CoA units to produce a linear polyketide chain. The nascent chain is then 
transferred, hydrolyzed and cyclized by NatF to form the 29-membered pronaphthomycin. 
The latter is dehydrated to form naphthomycin E (2.8). Finally, 2.8 is converted to 
naphthomycin A (2.1) by chlorination of C-30. Wu and coworkers were able to show that the 
halogenase gene nat1 is responsible for this final step.20 
1.1.5 Retrosynthetic Analysis of Naphthomycin K 
In order to prove if our proposed structure of naphthomycin K was correct and to provide 
material in sufficient quantities to allow for its further biological evaluation, we engaged in 
the total synthesis of 2.2. Our retrosynthesis, which is depicted in Scheme 3, was influenced 
by several considerations: 1) it should provide access to naphthomycins A (2.1) and E (2.8), 
so that we could test our biosynthetic hypothesis and 2) it should be convergent enough to 
target all members of the naphthomycin family by minor changes in the overall strategy. As 
such we expected naphthomycin K (2.2) to be formed from naphthomycin A (2.1) by an 
intramolecular hetero-Diels-Alder reaction. The latter would arise from naphthomycin E (2.8) 
by introduction of a chlorine substituent at C30. Naphthomycin E (2.8) is further dissected 
into four building blocks: naphthalene 2.17, stannane 2.18, phosphonate 2.19 and aldehyde 
2.20. While the linkage of building blocks 2.17, 2.19 and 2.20 should be feasible by Horner-
Wadsworth-Emmons (HWE) reaction, we envisioned that a double Stille-coupling would 
facilitate late-stage macrocyclization. This “double Stille stitching approach” would not only 
allow us to construct the challenging triene system but also would provide access to other 
naphthomycins when using the E-isomer of 2.18 and a naphthalene bearing a hydrogen 
instead of a methyl group at C2. 
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Scheme 3. Retrosynthetic analysis of naphthomycin K (2.2).  
From the very beginning, this project was a very fruitful collaboration between Ph.D. student 
Mesut Cakmak and myself. While Mesut Cakmak was responsible for the synthesis of the 
ansa chain of naphthomycin K, the goal of my work was to develop a scalable route to a 
unified naphthalene building block, which could be used for the synthesis of not only the 
naphthomycins, but also for the divergolides and ansalactam.  
1.1.6 1st Approach to the Naphthalene Core 
Our initial approach towards naphthalene building block 2.17 is depicted in Scheme 4 in a 
retrosynthetic format. As such, 2.17 would be excised to reveal cyano-naphthalene 2.21, β-
iodomethacrylic acid 2.22 and commercially available phosphonate 2.23. The linkage 
between 2.21 and phosphonate 2.23 was planned to be formed by nucleophilic attack of 
lithiated 2.23 at the cyano substituent of 2.21 and subsequent hydrolysis. The vinyl iodide 
2.22 would in turn be connected to the naphthalene core 2.21 by simple amide coupling. 
Finally, the suitably protected naphthalene core was expected to be formed by Diels-Alder 
reaction between a suitable quinone 2.26 and the novel cyano-substituted diene 2.25, followed 
by reduction and protection.  
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Scheme 4. 1st retrosynthetic analysis of naphthalene building block 2.17.  
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1.2 Published Results 
1.2.1 An Approach to Aminonaphthoquinone Ansamycins Using a Modified 
Danishefsky Diene 
Publication: Kuttruff, C. A.; Geiger, S.; Cakmak, M.; Mayer, P.; Trauner, D. Org. Lett. 2012, 
14, 1070–1073. 
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1.3 Unpublished Results 
1.3.1 Attempts to the Synthesis of 2.17 
With the methyl protected hydroquinone 2.27 in hand, the attachment of phosphonate 2.23 to 
the cyano group was attempted (Scheme 5). To this end, diethyl ethylphosphonate (2.23) was 
deprotonated using n-BuLi in THF at -78 °C and the resulting lithiated species 2.28 was 
reacted with cyano-naphthalene 2.27. However, only starting material was recovered despite 
the large excess of 2.28 that was used. We reasoned that the cyano group was not electrophilic 
enough for an attack to occur and hence tried to increase its reactivity by the addition of 
Lewis-acids.31 Unfortunately, no product formation was observed in the presence of AlCl3 or 
BF3·OEt2, even when the reaction mixture was refluxed for extended reaction times.  
 
Scheme 5. Attempted addition of a lithiated phosphonate 2.28 into cyanonaphthalene 2.27. 
We next tried to reduce the cyano group to a formyl group in order to increase its 
electrophilicity (Scheme 6). To this end, several conditions were screened, albeit with little 
success. In most cases, either decomposition was observed or a mixture of starting material 
2.27 and deacetylated starting material was isolated. Reduction was only achieved when 2.27 
was reacted with 5.5–6 equivalents of DIBAL-H at -78 °C for 1.5–2 h. However the yields 
were only moderate (42%–60%; determined by NMR) and the reaction was not reproducable. 
Furthermore, the product could not be separated from the remaining starting material.  
 
Scheme 6. Attempted reduction of the cyano group present in 2.27. 
To exclude the possibility that the acetyl group was responsible for the difficulties with the 
reduction, it was cleaved by treatment with conc. HCl in MeOH and the resulting free amine 
                                                
31 McKenna, M. T.; Proctor, G. R.; Young, L. C.; Harvey, A. L. J. Med. Chem. 1997, 40, 3516–3523. 
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2.31 was exposed to the reduction conditions (Scheme 7). Unfortunately, none of the 
attempted reductions gave any product.  
 
Scheme 7. Cleavage of the acetate in 2.27 and subsequent attempts to reduce the cyano group. 
1.3.2 2nd Approach to the Naphthalene Core 
Because 2.27 could not be further elaborated into the desired phosphonate 2.17, we devised a 
new strategy for the synthesis of 2.33, shown in Scheme 8. Inspired by Roush´s synthesis of 
(+)-damavaricin D,32 we reasoned that the challenging introduction of the phosphonate on the 
naphthalene should be feasible by either acylation of lithiated intermediate 2.34 using acyl-
phosphonate 2.35 or nucleophilic attack of lithiated phosphonate 2.28 on formyl naphthalene 
2.36 and subsequent oxidation. Both, 2.34 and 2.36 could in turn be traced back to amino-
protected bromonaphthalenes 2.37 and 2.38, both of which are key intermediates in our 
revised strategy (Scheme 8).  
 
Scheme 8. Revised strategy to 2.33 starting from a common building block. The two different retrosynthetic cuts 
and pathways are highlighted in colour.  
In the following two sections, the syntheses of the two different protected bromonaphthalenes 
2.37 and 2.38 are described.  
                                                
32 Roush, W. R.; Coffey, D. S.; Madar, D. J. J. Am. Chem. Soc. 1997, 119, 11331–11332. 
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1.3.2.1 Synthesis of Acetyl-protected Bromonaphthalene 2.37 
The synthesis of acetyl bromonaphthalene 2.37 commenced with the preparation of the 
known methyl-Danishefsky diene 2.42 (Scheme 9).33 Thus, 2-butanone was deprotonated 
using sodium methoxide and reacted with ethyl formate (2.39) to give sodium enolate 2.40,34 
which was methylated to afford enol ether 2.41 in very good yield over 2 steps. Compound 
2.41 was then transformed into the corresponding diene 2.42 by treatment with triethyl amine 
and TMSOTf in Et2O in 82% yield.35 After purification of the crude diene by distillation, it 
was ready to be used in the planned Diels-Alder reaction. The required dienophile, 6-chloro-
2-acetamidobenzoquinone (2.43), was synthesized in three steps from commercially available 
2,4-dichloro-6-nitrophenol following a procedure by Kelly and coworkers.36 With multigram 
quantities of the diene 2.42 and the dienophile 2.43 in hand, the stage was set for the crucial 
Diels-Alder reaction. Thus, 2.42 and 2.43 were combined in a pressure tube and heated at 
80 °C for 16 h. Subsequent aromatization was achieved by treatment of the crude with HCl 
(2%) in THF to give aminonaphthoquinone 2.44 in 88% yield as a single regioisomer, the 
structure of which was confirmed by X-ray crystallographic analysis (Scheme 9).  
 
Scheme 9. Synthesis and X-ray structure of aminonaphthoquinone 2.44. 
For the next step, a method for the regioselective monobromination of 2.44 was sought. Since 
there was no precedence for the targeted transformation, suitable conditions had to be found. 
Reaction of 2.44 with bromine in the presence of AcOH/NaOAc afforded the dibrominated 
compound 2.45 depicted in Scheme 10. Although this reaction did not give the desired 
product, the result was quite interesting and provided an important clue. During the reaction, 
                                                
33 (a) Barrett, A. G. M.; Carr, R. A. E.; Attwood, S. V.; Richardson, G.; Walshe, N. D. A. J. Org. Chem. 1986, 
51, 4840–4856; (b) Clive, D.; Bergstra, R. J. J. Org. Chem. 1991, 56, 4976–4977; (c) Miyashita, M.; Yamasaki, 
T.; Shiratani, T.; Hatakeyama, S.; Miyazawa, M.; Irie, H. Chem. Comm. 1997, 18, 1787–1788. 
34 Gupta, R. C.; Larsen, D. S.; Stoodley, R. J.; Slawin, A. M. Z.; Williams, D. J. J. Chem. Soc. Perkin Trans. 1 
1989, 739–749. 
35 Yamashita, Y.; Saito, S.; Ishitani, H.; Kobayashi, S. J. Am. Chem. Soc. 2003, 125, 3793–3798. 
36 Kelly, T. R.; Echavarren, A.; Behforouz, M. J. Org. Chem. 1983, 48, 3849–3851. 
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the bromide anion, which is formed after initial reaction of the arene with Br2, proved 
sufficiently nucleophilic to undergo a Michael-addition to the α,β-unsaturated system of the 
quinone. As such, we believe that it is feasible to install the required C30-substituents of the 
different naphthomycines by simply reacting naphthomycin E (2.8) with the corresponding 
nucleophile. Although compound 2.45 was not further carried on through the synthesis, it was 
used to test the subsequent MOM protection. Interestingly, when 2.45 was reacted with 
MOMCl and DIPEA overnight, in addition to the expected MOM-ether 2.46, compound 2.47 
was identified and its structure was verified through X-ray crystallography.  
 
Scheme 10. Interesting results from initial bromination and MOM protection attempts. 
In order to achieve the key monobromination ortho to the hydroxy group present in 2.44, 
several bromination reagents, solvents and bases were screened. This resulted in the finding 
that reaction of 2.44 with N-bromosuccinimide and NaOH in CHCl3 cleanly yielded the target 
compound 2.48 in 78% yield. The structure of this monobrominated aminonaphthoquinone 
was subsequently proven by single X-ray crystallographic analysis (Scheme 11). Protection of 
phenol 2.48 as a MOM ether was accomplished quantitatively by treatment with bromomethyl 
methyl ether and Hünig’s base. The resulting naphthoquinone 2.49 was reduced using sodium 
borohydride and CeCl3 in a THF/water mixture and the resulting air-sensitive 1,4-
dihydroquinone was methylated in situ by treatment with dimethyl sulfate and KOH as a base 
under exclusion of oxygen. This one-pot reduction-methylation procedure afforded the 
desired 1,4-di-O-methyldihydroquinone 2.37 in excellent yield.  
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Scheme 11. Synthesis of the key acetyl protected bromonaphthalene 2.37.  
As such, an efficient route for the key intermediate 2.37 was developed which allowed for its 
synthesis in only seven steps (longest linear sequence) from commercially available starting 
materials with an overall yield of 47%. 
1.3.2.2 Synthesis of Boc-protected Bromonaphthalene 2.38 
Having worked out a reliable and scalable route to 2.37, the Boc protected analogue 2.38 was 
next targeted. To this end, 2-tert-butoxycarbonylamino-1,4-benzoquinone (2.52) was first 
prepared according to a recently published procedure (Scheme 12).37 This included Boc-
protection of 2,5-dimethoxyaniline (2.50) to give 2.51 followed by oxidation using PhI(OAc)2 
to afford 2.52. Whilst the first step of this protocol could easily be scaled up to decagram 
quantities, it should be noted that the yield of the oxidation step rapidly decreased when the 
reaction was scaled up. 
 
Scheme 12. Synthesis of Boc-protected aminoquinone 2.52. 
With sufficient material in hand, the synthesis of 2.56 was carried out as shown in Scheme 13. 
It commenced with the Diels-Alder reaction between diene 2.42 and quinone 2.52, which was 
performed in a pressure tube at 75 °C. In this case however, a further oxidation step was 
necessary to aromatize the Diels-Alder adduct. This could be effected when a suspension of 
the crude product mixture and silica gel was stirred in CHCl3/acetone and subsequently 
pushed through a silica gel column. As a result, aminonaphthoquinone 2.53 was obtained in 
                                                
37 Nawrat, C. C.; Lewis, W.; Moody, C. J. J. Org. Chem. 2011, 76, 7872–7881. 
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77% as a single isomer, whose structure was unambiguously confirmed through X-ray 
crystallographic analysis. Selective monobromination of Boc-protected aminonaphtho-
quinone, applying optimized conditions, gave compound 2.54 in very good yield. Again, the 
structure of the product was verified by X-ray crystallographic analysis. The next 2 steps were 
analogous to the route shown in Scheme 11. Conversion of bromophenol 2.54 into the 
corresponding MOM-ether 2.55 proceeded in almost quantitative yield. Subsequent reduction 
of 2.55 using sodium borohydride and in situ protection of the formed hydroquinone as the 
dimethyl ether using dimethyl sulfate (see above) provided key Boc-protected 
bromonaphthalene 2.38 in 89% yield. Since at this point, it was not clear if the NH-proton 
would be disadvantageous for the planned lithiation of 2.38, it was shown that 2.38 could 
further be protected as the Di-Boc-bromonaphthalene 2.56 using Boc2O and DMAP (56% 
unoptimized yield). 
 
Scheme 13. Efficient synthesis of Boc-protected bromonaphthalene 2.38 starting from the known building blocks 
2.42 and 2.52. 
In summary, Boc-protected bromonaphthalene could be synthesized on a gram scale starting 
from the known building blocks 2.42 and 2.52 in four steps with an overall yield of 59%. 
1.3.2.3 Synthesis of (Z)-vinyl iodide 2.22 
(Z)-3-iodo-2-methylpropenoic acid 2.22, which was later intended to be coupled to the amino 
group of the naphthalene building block (see section 1.1.6), was synthesized in three steps as 
shown in Scheme 14. Cu-catalyzed methylmagnesation of propargyl alcohol (2.57) and 
trapping of the reactive intermediate with iodine, using a modified version of a reported 
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protocol,38 yielded vinyl alcohol 2.58 in 66% yield. Allylic oxidation using manganese 
dioxide furnished sensitive aldehyde 2.59, which was directly used in the next step without 
purification. Finally, Pinnick oxidation of 2.59 was carried out following a procedure by Liu 
and Negishi39 and afforded the desired (Z)-vinyl iodide 2.22, the structure of which was 
unambiguously confirmed by X-ray crystallographic analysis.  
 
Scheme 14. Synthesis and X-ray structure of (Z)-vinyl iodide 2.22. 
 
                                                
38 Hiroya, K.; Takuma, K.; Inamoto, K.; Sakamoto, T. Heterocycles 2009, 77, 493–505. 
39 Liu, F.; Negishi, E. J. Org. Chem. 1997, 62, 8591–8594. 
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2 Towards the Total Synthesis of Divergolides C and D 
2.1 Isolation, Structure and Biological Activities 
In 2011, Hertweck et al. reported the isolation, structural elucidation and biological activities 
of four novel ansamycins, which were named divergolides A–D (2.60–2.61 and 2.3–2.4).40 
They were isolated from an endophyte of the mangrove tree Bruguiera gymnorrhiza. This 
small tree is widely distributed in the tropics and grows on the seaward side of estuaries in 
mud. The bark and the root of B. gymnorrhiza is used to treat hemostasia, throat inflammation 
and diarrhea in traditional Chinese medicine.41  
Hertweck´s group was able to elucidate the structures of the divergolides A–D based on 
careful 2D-NMR analysis and high resolution mass spectrometry. In addition, the absolute 
configuration of 2.60 was confirmed by X-ray crystallography and CD spectroscopy.   
 
Figure 9. Structures of the recently isolated novel ansamycins divergolides A–D (2.60–2.61 and 2.3–2.4). 
Divergolides C (2.3) and D (2.4) share a common naphthoquinone core (highlighted in blue), which is also present 
in the naphthomycins (see section 1.1.2).  
In order to evaluate the biological activities of the divergolides, they were tested in a number 
of antimicrobial, antiproliferative and cytotoxic assays. This screening revealed that 
                                                
40 Ding, L.; Maier, A.; Fiebig, H.-B.; Görls, H.; Lin, W.-H.; Peschel, G.; Hertweck, C. Angew. Chem. Int. Ed. 
2011, 50, 1630–1634. 
41 Han, L.; Huang, X. S.; Sattler, I.; Dahse, H. M.; Fu, H. Z.; Lin, W. H.; Grabley, S. J. Nat. Prod. 2004, 67, 
1620–1623. 
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divergolide A (2.60) showed the strongest activity against Mycobacterium vaccae, while 
divergolide B (2.61) was more active against Enterococcus faecalis. Divergolide D (2.4) 
displayed activity against Bacillus subtilis and Staphylococcus aureus and was the only 
divergolide which showed pronounced activity against a number of tumor cell lines with IC50 
values ranging from 1.0 to 2.0 µM.31 This preliminary data renders the divergolides 
(particularly divergolides A and D) interesting and promising candidates for further drug 
development.  
2.2 Biosynthesis 
Although at first glance, the structures of the divergolides seem to differ profoundly, a closer 
inspection reveals that they are likely to originate from a common biosynthetic precursor. An 
intriguing biosynthesis was proposed by Hertweck et al. and is shown in Scheme 15. As such, 
the divergolides can be traced back to the AHBA-primed polyketide backbone 2.62 which is 
transformed into lactone intermediate 2.63 by the action of a Bayer-Villigerase.42 The latter 
could undergo an optional acyl migration, that would account for the different lengths of the 
ansa chains present in the divergolides. Shifting of the double bond could occur in analogy to 
what has been observed for other polyketides.43 The unsual branching in the side chain could 
be attributed to the incorporation of isobutyryl-malonyl-CoA (2.64), a novel branched 
extender unit.44 The most striking feature of Hertweck`s biosynthetic proposal however is the 
insight that the structural diversity amongst the four divergolides could be generated through 
different types of cyclizations between the ansa chain and the aromatic moiety. Specifically, 
the tricyclic ring system in 2.60 would be formed via attack of the phenolic hydroxy group on 
the more distant carbonyl group to form an acetal and subsequent addition of the formed 
hydroxy group to the side-chain double bond (Scheme 15, route a). Alternatively, attack of 
the phenol at the vinylogous carbonyl group followed by elimination of water would give rise 
to the exomethylene-2H-chromene system in 2.61 (Scheme 15, route b). On the other hand, 
attack of the methylene group at the quinone would lead to aminonaphthoquinone 
intermediate 2.65 (Scheme 15, route c). This could further react via attack of the carbonyl-
activated methylene in a Michael- (Scheme 15, route d) or Aldol-fashion (Scheme 15, route e) 
                                                
42 Gibson, M.; Nur-e-alam, M.; Lipata, F.; Oliveira, M. A.; Rohr, J. J. Am. Chem. Soc. 2005, 127, 17594–17595. 
43 (a) Taft, F.; Brünjes, T.; Knobloch, T.; Floss, H. G.; Kirschning, A. J. Am. Chem. Soc. 2009, 131, 3812–3813; 
(b) Moldenhauer, J.; Götz, D. C. G.; Albert, C. R.; Bischof, S. K.; Schneider, K.; Süßmuth, R.; Engeser, M.; 
Groß, H.; Bringmann, G.; Piel, J. Angew. Chem. Int. Ed. 2010, 49, 1465–1467; (c) Kusebauch, B.; Busch, B.; 
Scherlach, M.; Roth, M.; Hertweck, C. Angew. Chem. Int. Ed. 2010, 49, 1460–1464. 
44 Chan, Y. A.; Podevels, A. M.; Kevany, B. M.; Thomas, M. G. Nat. Prod. Rep. 2009, 26, 90–114. 
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on the quinone to give either the seven-membered lactam ring present in divergolide C (2.3), 
or the γ-lactam of divergolide D (2.4) (Scheme 15, route d and e).  
 
Scheme 15. Hertweck´s proposed biosynthesis of the divergolides. The different chromophores present in the 
divergolides could all arise from the same precursor.  
2.3 Retrosynthetic Analysis 
Both divergolide C (2.3) and divergolide D (2.4) share a common aminonaphtho-
(hydro)quinone core, for which a synthesis had previously been developed in the course of the 
naphthomycin K project. This fact together with their intriguing biosynthesis and their range 
of biological activities motivated us to target the total synthesis of divergolides C (2.3) and D 
(2.4). Our approach is outlined retrosynthetically in Scheme 16, exemplified for divergolide D 
(2.4). 
We envisaged that the different aromatic chromophores present in divergolides C (2.3) and D 
(2.4) could be formed from a common presursor by means of a biomimetic cyclization, 
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closing metathesis and prior amide formation would lead to left-hand and right-hand 
fragments 2.67 and 2.68, respectively. Naphthalene building block 2.67 could further be 
dissected into formyl-naphthalene 2.69 and bromide 2.70. In a forward-sense, these fragments 
would be connected by lithiation of bromide 2.70 and subsequent addition into the formyl 
group of 2.69, followed by oxidation. The formyl group present in 2.69 in turn was 
envisioned to be installed via lithiation of bromonapthalene 2.38 and subsequent trapping 
with DMF whereas bromide 2.70 could be traced back to chiral alcohol 2.71. 
 
Scheme 16. Retrosynthetic analysis of divergolide C (2.3). 
The retrosynthesis of divergolide D (2.4) would follow the same lines with the only 
differences being the final formation of the heterocycle and the connectivity in fragment 2.68.  
2.4 Unpublished Results 
Since the synthesis of the naphthalene building block 2.38 that we planned to use in the total 
synthesis of divergolides C and D (2.3 and 2.4) is already described in section 1.3.2.2, the 
following section will only cover results towards an enantioselective synthesis of building 
block 2.71.  
At the outset of our studies, we found two publications reporting the enantioselective 
synthesis of (R)-alcohol 2.71. While we considered Liang´s route45 to 2.71 as less suitable for 
our purposes, the one-step protocol published by Morken et al.46 seemed more attractive. 
                                                
45 Liang, B.; Negishi, E. Org. Lett. 2008, 10, 193–195. 
46 Morken, J. P.; Didiuk, M. T.; Hoveyda, A. H. J. Am. Chem. Soc. 1993, 115, 6997–6998. 
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Accordingly, the requisite pyran 2.74 was prepared in three steps from commercially 
available pyranone 2.72 as depicted in Scheme 17. Thus, treatment of ketone 2.72 with 
LiAlH4 in THF furnished the corresponding alcohol 2.73 in 88% yield. Subsequent 
mesylation followed by DBU-mediated dehydration afforded pyran 2.74.47  
Compound 2.74 was next subjected to zirconium-catalyzed asymmetric carbomagnesation 
following the literature procedure to yield alcohol 2.71 in 42% yield.37  
 
Scheme 17. Four-step synthesis of 2.71 using an enantioselective carbomagnesation reaction.  
Although this route is quite short, it was abandoned since it requires the use of an expensive 
catalyst and is thus not readily scalable.  
We next aimed for a more practical route towards alcohol 2.71, starting from inexpensive 
materials. For comparison purposes, Morken et al. had synthesized the enantiomer of alcohol 
2.71 using an asymmetric conjugate addition approach. A similar approach was next 
attempted, albeit starting from chiral oxazolidinone auxiliary 2.75, which was readily 
available from valine. 
The planned synthesis of 2.71 commenced with deprotonation of (S)-4-isopropyloxazolidin-2-
one (2.75) with n-BuLi, followed by acylation with freshly prepared (E)-pent-2-enoyl 
chloride48 to give imide 2.76 in excellent yield (Scheme 18). Conjugate addition of 
vinylmagnesium bromide in the presence of CuBr·SMe2 in THF afforded alkene 2.77 in very 
good yield, albeit as a 2:1 mixture of diastereoisomers that could not be separated by flash 
column chromatography. Although it was already clear at this point that the 
diastereoselectivity of this reaction was not acceptably high to merit adopting this route, the 
material in hand was used to investigate the subsequent steps. Thus, reaction of alkene 2.77 
with lithium hydroperoxide in THF/H2O effected the removal of the chiral auxiliary and gave 
acid 2.78 in very good yield.49 Finally, reduction to the corresponding, volatile alcohol 2.79 
was achieved in 93% by refluxing the acid 2.78 with LiAlH4 in THF. 
                                                
47 Suto, M. J.; Stier, M. A.; Werbel, L. M.; Arundel-Suto, C. M.; Leopold, W. R.; Elliott, W. E.; Sebolt-Leopold, 
J. S. J. Med. Chem. 1991, 34, 2484–2488. 
48 Zhang, F.-L.; Schweizer, W. B.; Xu, M.; Vasella, A. Helv. Chim. Acta 2007, 90, 521–534. 
49 Zask, A.; Birnberg G.; Cheung, K.; Kaplan, J.; Niu, C.; Norton, E.; Suayan, R.; Yamashita, A.; Cole, D.; 
Tang, Z.; Krishnamurthy, G.; Williamson, R.; Khafizova, G.; Musto, S.; Hernandez, R.; Annable, T.; Yang, X.; 
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Scheme 18. Using auxiliary 2.75, the desired alcohol 2.71 could be synthesized, albeit as a mixture of 
enantiomers.  
In spite of the fact that this alternative route was short, robust and scalable, it was not suitable 
because of the poor asymmetric induction from chiral auxiliary 2.75.  
Based on the alternative route that Morken et al. had used to synthesize the (S)-enantiomer of 
2.71 using (S)-γ-trityloxymethyl-γ-butyrolactam50 as a chiral auxiliary, we reasoned that its 
enantiomer (R)-γ-trityloxymethyl-γ-butyrolactam (2.81) should give rise to the desired (R)-
configured alcohol 2.71. The preparation of chiral auxiliary 2.81 started with tritylation51 of 
literature known lactam alcohol 2.8052 in 67% yield (Scheme 19). The resulting lactam ether 
2.81 was next acylated to the imide 2.82 in 76% yield as described above by following a 
procedure from Evans et al.53 The following asymmetric conjugate addition was carried out as 
described by Tomioka et al.41 and afforded the α,β-unsaturated imide 2.83 as a single 
diastereoisomer. Due to time constraints, I had to leave the project at this point. However, it 
could subsequently been shown by Anastasia Hager, a Ph.D. student in our group, that this 
route furnished the desired enantiopure (R)-alcohol 2.71. 
 
Scheme 19. Use of (R)-γ-trityloxymethyl-γ-butyrolactam (2.81) allowed for a diastereoselective synthesis of 
intermediate 2.83. 
                                                                                                                                                   
Discafani, C.; Beyer, C.; Greenberger, L. M.; Loganzo, F.; Ayral-Kaloustian, S. J. Med. Chem. 2004, 47, 4774–
4786. 
50 Tomioka, K.; Suenaga, T.; Koga, J. Tetrahedron Lett. 1986, 27, 369–372. 
51 Adam, W.; Zhang, A. Eur. J. Org. Chem. 2004, 147–152. 
52 (a) Amstutz, R.; Ringdahl, B.; Karlen, B.; Roch, M.; Jenden, D. J. J. Med. Chem. 1985, 28, 1760–1765; (b) 
Valasinas, A.; Frydman, B.; Friedmann, H. C. J. Org. Chem. 1992, 57, 2158–2160. 
53 Evans, D. A.; Bartroli, J.; Shih, T. L. J. Am. Chem. Soc. 1981, 103, 2127–2129. 
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3 Experimental Part 
3.1 General Experimental Details 
Unless stated otherwise, all reactions were performed in oven-dried or flame-dried glassware 
under a positive pressure of nitrogen. Commercial reagents and solvents were used as 
received with the following exceptions. Tetrahydrofuran (THF) was distilled from 
benzophenone and sodium immediately prior to use. Triethylamine, diisopropylamine and 
diisopropylethylamine were distilled over calcium hydride immediately before use. Reactions 
were magnetically stirred and monitored by NMR spectroscopy or analytical thin-layer 
chromatography (TLC) using E. Merck 0.25 mm silica gel 60 F254 precoated glass plates. 
TLC plates were visualized by exposure to ultraviolet light (UV, 254 nm) and/or exposure to 
an aqueous solution of ceric ammoniummolybdate (CAM), an aqueous solution of potassium 
permanganate (KMnO4), an acidic solution of vanillin or a solution of ninhydrin in ethanol 
followed by heating with a heat gun. Flash column chromatography was performed as 
described by Still et al. employing silica gel (60 Å, 40-63 µm, Merck) and a forced flow of 
eluant at 1.3–1.5 bar pressure.54 Yields refer to chromatographically and spectroscopically (1H 
and 13C NMR) pure material. 
3.2 Instrumentation 
Proton nuclear magnetic resonance (1H NMR) spectra were recorded on Varian VNMRS 300, 
VNMRS 400, INOVA 400 or VNMRS 600 spectrometers. Proton chemical shifts are 
expressed in parts per million (δ scale) and are calibrated using residual undeuterated solvent 
as an internal reference (CDCl3: δ 7.26, CD2Cl2: δ 5.32, DMSO-d6: δ 2.50). Data for 1H NMR 
spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, br = broad, app = apparent, or combinations thereof. Carbon nuclear 
magnetic resonance (13C NMR) spectra were recorded on Varian VNMRS 300, VNMRS 400, 
INOVA 400 or VNMRS 600 spectrometers. Carbon chemical shifts are expressed in parts per 
million (δ scale) and are referenced to the carbon resonances of the solvent (CDCl3: δ 77.0, 
CD2Cl2: δ 53.84, DMSO-d6: δ 39.5). Infrared (IR) spectra were recorded on a Perkin Elmer 
Spectrum BX II (FTIR System). IR data is reported in frequency of absorption (cm-1). Mass 
spectroscopy (MS) experiments were performed on a Thermo Finnigan MAT 95 (EI) or on a 
                                                
54 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925. 
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Thermo Finnigan LTQ FT (ESI) instrument. Optical rotations were obtained on a Perkin 
Elmer 241 Polarimeter.  
3.3 Synthetic Procedures 
3.3.1 Naphthomycin K Project 
 
Amine 2.31: 
To a suspension of cyano-naphthalene 2.27 (67 mg, 213 µmol, 1.0 equiv.) in MeOH (4 mL) in 
a pressure tube was added conc. HCl (0.5 mL). The pressure tube was sealed and heated to 80 
°C in an oil bath for 40 min. After cooling to rt, the reaction mixture was adjusted to pH = 7 
by addition of an aq. solution of NaOH (2 M). The resulting white suspension was extracted 
with CHCl3 (3 × 10 mL) and the combined organic layers were, dried over sodium sulfate, 
filtered and concentrated under reduced pressure. Purification of the residue by flash column 
chromatography (silica gel, CHCl3:acetone = 25:1) provided amine 2.31 (56 mg, 206 µmol, 
97%) as a grey solid. 
TLC (CHCl3:acetone = 10:1), Rf = 0. 4  (UV/CAM)  
M.p.: 110–115 °C 
1H NMR (600 MHz, CDCl3) δ: 7.84–7.84 (m, 1 H), 6.44 (s, 1 H), 4.00 (s, 3 H), 3.96 (s, 3 H), 
3.80 (s, 3 H), 2.44 (d, J = 0.8 Hz, 3 H).  
13C NMR (150 MHz, CDCl3) δ: 161.2, 151.5, 136.0, 133.0, 131.8, 126.6, 126.5, 117.6, 116.9, 
99.7, 99.5, 61.6, 60.1, 55.8, 16.8. 
IR (Diamond-ATR, neat) νmax: 2359, 2338, 2210, 2156, 1956, 1732, 1716, 1699, 1683, 1652, 
1622, 1558, 1539, 1505, 1472, 1456, 1388, 1236, 1201, 1064, 1001, 963, 899, 833, 812, 668 
cm-1. 
HRMS (ESI) calcd for C15H17N2O3 [M+H]+: 273.1234; found: 273.1235. 
 
 
 
 
HCl (conc.), MeOH
80 °C, 40 min
(97%) MeO
OMe
OMe
NH2
2.31
MeO
OMe
OMe
NHAc
2.27
CN CN
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2-methyl-3-oxobutanal sodium salt (2.40): 
To a suspension of sodium methoxide (10.4 g, 192 mmol, 0.96 equiv.) in dry Et2O (180 mL) 
was added a mixture of 2-butanone (17.9 mL, 200 mmol, 1.00 equiv.) and ethyl formate 
(2.39) (17.8 mL, 240 mmol, 1.20 equiv.) over 5 min at 0 °C. The reaction mixture was 
warmed to rt and stirred for 16 h. The white precipitate was filtered off, washed with Et2O 
(2 × 100 mL) and dried under high vacuum overnight to yield the product 2.40 (20.7 g, 170 
mmol, 85%) as a white solid.  
1H NMR (400 MHz, D2O) δ: 9.01 (s, 1 H), 2.21 (s, 3 H), 1.60 (s, 3 H).  
HRMS (EI) calcd for C5H7O2Na [M]+•: 122.0344; found: 122.0342. 
 
 
 
(E)-4-methoxy-3-methylbut-3-en-2-one (2.41): 
2.40 (10.0 g, 82 mmol, 1.0 equiv.) was dissolved in dry DMF (100 mL) and the solution was 
cooled to 0 °C. Dimethyl sulfate (15.5 mL, 164 mmol, 2.0 equiv.) was added over 30 min via 
syringe pump and the reaction mixture was stirred at 0 °C for 5 h. An aq. solution of K2CO3 
(1 M, 100 mL) and MeOH (6 mL) were added and the reaction mixture was warmed to rt. The 
mixture was extensively extracted with EtOAc until TLC monitoring showed that the 
extraction was complete. The combined organic layers were washed with an aq. solution of 
LiCl (10%, 500 mL) (if TLC indicated product in the aq. LiCl solution layer, it was re-
extracted with EtOAc), dried over sodium sulfate and concentrated in vacuo. The crude 
material was purified by flash column chromatography (silica gel, gradient: hexanes:Et2O = 
2:1 → 1:1) to afford the title compound 2.41 (8.32 g, 72.9 mmol, 89%) as a light yellow oil. 
Note: Due to its volatility, the pressure should not be lower than 100 mbar (at 40 °C water 
bath temperature) during rotary evaporation. The clean product should also be stored at -78 
°C due to its tendency to decompose.  
TLC (hexanes:EtOAc = 1:1), Rf = 0.41 (KMnO4) 
1H NMR (300 MHz, CDCl3) δ: 7.19 (q, J = 1.2 Hz, 1 H), 3.83 (s, 3 H), 2.16 (s, 3 H), 1.65 (d, 
J = 1.2 Hz, 3 H).  
2-butanone
NaOMe, Et2O
0 °C  rt, 16 h
(85%)H OEt
O
O
O– Na+
2.402.39
Me2SO4, DMF
0 °C, 5 h
(89%)
O
OMe
2.41
O
O– Na+
2.40
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13C-NMR (75 MHz, CDCl3) δ = 197.3, 160.2, 117.6, 61.2, 25.1, 8.0.  
IR (Diamond-ATR, neat) νmax: 2942, 1631, 1455, 1396, 1368, 1303, 1239, 1143, 1109, 973, 
935, 823, 787, 755, 732 cm-1. 
HRMS (EI) calcd for C6H10O2 [M]+•: 114.0681; found: 114.0677. 
 
 
 
(E)-((4-methoxy-3-methylbuta-1,3-dien-2-yl)oxy)trimethylsilane (2.42) 
To a solution of enol ether 2.41 (2.76 g, 24.2 mmol, 1.0 equiv.) in dry Et2O (70 mL) was 
added triethylamine (8.4 mL, 60.5 mmol, 2.5 equiv.) at rt. The cloudy solution was stirred for 
5 min, cooled to 0 °C and a solution of TMSOTf (5.25 mL, 29.0 mmol, 1.2 equiv.) in dry 
Et2O (10 mL) was added dropwise. The brown-orange reaction mixture was stirred at 0 °C for 
4.5 h and subsequently, hexanes (30 mL) and sat. aq. NaHCO3 (50 mL) were added. The 
organic layer was separated and the aq. layer was extracted with hexanes (3 × 100 mL). The 
combined organic layers were washed with water (1 × 200 mL) and sat. aq. NaCl (1 × 300 
mL), dried over sodium sulfate, filtered and subjected to rotary evaporation (100 mbar). The 
residue was purified by fractional distillation (42 °C, 9 ⋅ 10–1 mbar) to afford the product 2.42 
(3.68 g, 19.8 mmol, 82%) as a colorless oil. 
1H NMR (300 MHz, CDCl3) δ: 6.51–6.50 (m, 1 H), 4.23 (d, J = 1.4 Hz, 1 H), 4.12 (d, J = 1.3 
Hz, 1 H), 3.67 (s, 3 H), 1.69 (d, J = 1.3 Hz, 3 H), 0.23 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ = 156.2, 147.1, 111.4, 89.1, 60.1, 10.0, 0.1.  
IR (Diamond-ATR, neat) νmax: 2958, 2840, 2361, 2340, 1656, 1590, 1456, 1387, 1353, 1306, 
1252, 1228, 1136, 1019, 1005, 972, 840, 816, 753, 689 cm-1. 
HRMS (EI) calcd for C9H18O2Si [M]+•: 186.1076; found: 186.1063. 
 
 
 
 
 
TMSOTf, Et3N, Et2O
0 °C, 4.5 h
(82%)
TMSO
OMe
2.42
O
OMe
2.41
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Acetyl-aminonaphthoquinone 2.44: 
A pressure tube was charged with quinone 2.43 (3.37 g, 16.9 mmol, 1.0 equiv.) and dry 
benzene (60 mL). To this suspension was added a solution of diene 2.42 (3.33 g, 17.7 mmol, 
1.05 equiv.) in dry benzene (15 mL). The pressure tube was sealed and the orange reaction 
mixture was heated to 80 °C for 16 h. The mixture was cooled to rt, transferred into a round 
bottom flask and the solvent was removed in vacuo. The residue was dissolved in THF (100 
mL) and HCl (2%, 20 mL) was added. The resulting solution turned black and was stirred 
under ambient atmosphere at rt for 24 h. Silica gel was added, the reaction mixture was 
concentrated, and the crude was loaded directly onto a silica gel column for chromatography 
(gradient: CHCl3:acetone = 20:1 → 10:1 → 5:1 → 1:1; then CH2Cl2:MeOH = 5:1 → 2:1). 
The fractions containing the product were combined and filtered and the eluent was removed 
under reduced pressure to afford acetyl-aminonaphthoquinone 2.44 (3.64 g, 14.8 mmol, 88%) 
as a crystalline, orange-brown powder.  
TLC (CHCl3:acetone = 10:1), Rf = 0.56 (visible/CAM)  
M.p.: 220 °C (decomp.)  
1H NMR (400 MHz, DMSO-d6) δ: 11.05 (s, 1 H), 9.80 (s, 1 H), 7.79 (d, J = 0.8 Hz, 1 H), 
7.55 (s, 1 H), 7.30 (s, 1 H), 2.23 (s, 3 H), 2.22 (s, 3 H). 
13C NMR (100 MHz, DMSO-d6) δ: 185.3, 179.2, 171.2, 161.7, 141.4, 131.8, 130.3, 129.6, 
121.8, 115.4, 110.5, 24.6, 15.9.  
IR (Diamond-ATR, neat) νmax: 3338, 1721, 1653, 1629, 1609, 1573, 1483, 1336, 1317, 1260, 
1196, 1066, 1000, 964, 876, 788, 739, 695 cm-1. 
HRMS (EI) calcd for C13H11NO4 [M]+•: 245.0688; found: 245.0684. 
 
 
 
Dibromo-naphthoquinone 2.45 
To a suspension of acetyl-aminonaphthoquinone 2.44 (40 mg, 0.16 mmol, 1.0 equiv.) and 
NaOAc (44 mg, 0.54 mmol, 3.3 equiv.) in conc. AcOH (3 mL) was added a solution of 
TMSO
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bromine (9 µL, 0.17 mmol, 1.05 equiv.) in conc. AcOH (1 mL) at rt. The reaction mixture 
was heated at 90 °C for 2 h and then cooled to rt. Water (5 mL) was added and the mixture 
was extracted with CHCl3 (3 × 10 mL). The combined organic layers were dried over sodium 
sulfate, filtered and concentrated in vacuo. Purification of the crude product by flash column 
chromatography (silica gel, gradient: CHCl3:acetone = 15:1 → 10:1) afforded the product 
2.45 (44 mg, 109 µmol, 67%) as a yellow solid. 
TLC (CHCl3:acetone = 10:1), Rf = 0.38 (UV/CAM)  
M.p.: 197 °C 
1H NMR (400 MHz, DMSO-d6) δ: 10.00 (s, 1 H), 7.83 (d, J = 0.8 Hz, 1 H), 2.37 (d, J = 0.7 
Hz, 3 H), 2.09 (s, 3 H).  
13C-NMR (100 MHz, DMSO-d6) δ = 176.8, 176.5, 167.9, 158.3, 142.9, 131.8, 130.7, 129.1, 
127.9, 125.0, 110.9, 22.9, 17.4.  
IR (Diamond-ATR, neat) νmax: 3241, 2361, 1686, 1664, 1649, 1619, 1579, 1540, 1502, 1470, 
1415, 1372, 1342, 1256, 1217, 1171, 1085, 1042, 1020, 982, 917, 859, 831, 820, 758, 706, 
679, 664 cm-1. 
HRMS (ESI) calcd for C13H8Br2NO4 [M-H]–: 399.8826; found: 399.8826. 
 
 
 
MOM-Dibromo-naphthoquinones 2.46 and 2.47 
To a solution of 2.45 (49 mg, 122 µmol, 1.0 equiv.) in dry CH2Cl2 (6 mL) was added DIPEA 
(53 µL, 302 µmol, 2.0 equiv.) and at rt. The solution was cooled to 0 °C, MOMCl (37 µL, 
435 µmol, 3.6 equiv.) was added and the reaction mixture was warmed to rt and stirred for 19 
h before it was quenched by addition of sat. aq. NaHCO3 (5 mL). The mixture was extracted 
with CHCl3 (3 × 10 mL) and the combined org. layers were dried over sodium sulfate, filtered 
and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel, gradient: CHCl3:acetone = 30:1) to yield 2.46 (31 mg, 69 µmol, 
57%) and 2.47 (14 mg, 28 µmol, 23%) as a yellow solid. 
Analytical data for compound 2.46: 
TLC (hexanes:EtOAc = 10:1), Rf = 0.30 (UV/CAM)  
M.p.: 194 °C 
2.45
O
O
NHAc
HO
Br
Br
MOMCl, DIPEA
CH2Cl2, rt, 19 h
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O
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Br
Br
O
O
N
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O
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1H NMR (400 MHz, CDCl3) δ: 7.96 (d, J = 0.7 Hz, 1 H), 7.58 (br s, 1 H), 5.17 (s, 2 H), 3.66 
(s, 3 H), 2.50 (d, J = 0.7 Hz, 3 H), 2.27 (s, 3 H).  
13C-NMR (100 MHz, CDCl3) δ = 177.8, 175.8, 166.6, 160.3, 141.3, 139.7, 130.0, 129.3, 
128.7, 128.6, 119.6, 100.4, 58.1, 24.2, 18.1.  
IR (Diamond-ATR, neat) νmax: 3243, 1684, 1668, 1656, 1612, 1580, 1519, 1457, 1374, 1323, 
1283, 1260, 1224, 1189, 1168, 1085, 1036, 980, 921, 858, 835, 758, 734, 706, 692 cm-1. 
HRMS (ESI) calcd for C15H14Br2NO5 [M+H]+: 445.9233; found: 445.9239. 
Analytical data for compound 2.47: 
TLC (CHCl3:acetone = 10:1), Rf = 0.87 (UV/CAM)  
M.p.: 183 °C 
1H NMR (600 MHz, CDCl3) δ: 7.96 (s, 1 H), 5.46 (s, 2 H), 5.18 (s, 2 H), 3.67 (s, 3 H), 3.59 
(s, 3 H), 2.50 (s, 3 H), 1.92 (s, 3 H).  
13C-NMR (150 MHz, CDCl3) δ = 177.2, 176.5, 162.3, 159.9, 149.7, 139.1, 130.0, 129.2, 
128.6, 123.7, 119.1, 100.4, 93.7, 58.1, 58.0, 18.8, 18.0.  
IR (Diamond-ATR, neat) νmax: 3242, 1684, 1667, 1611, 1581, 1521, 1376, 1322, 1262, 1224, 
1206, 1170, 1158, 1082, 1020, 980, 922, 906, 846, 759, 737, 691 cm-1. 
 
 
 
Bromo-aminonaphthoquinone 2.48: 
To a suspension of Acetyl-protected aminonaphthoquinone 2.44 (100 mg, 0.41 mmol, 1.0 
equiv.) in CHCl3 (50 mL) was added NaOH (20 mg, 0.49 mmol, 1.2 equiv.) and N-
Bromosuccinimide (87 mg, 0.49 mmol, 1.2 equiv.) and the orange reaction mixture was 
stirred at rt for 16 h. The solvent was then evaporated in vacuo and the crude product was 
purified by flash column chromatography (silica gel, CHCl3:acetone = 20:1) to provide the 
title compound 2.48 (103 mg, 0.32 mmol, 78%) as an orange solid. 
TLC (CHCl3:acetone = 10:1), Rf = 0.49  (visible/UV/CAM)  
M.p.: 183 °C (decomp.) 
1H NMR (400 MHz, DMSO-d6) δ: 10.40 (br s, 1 H), 9.82 (s, 1 H), 7.89 (s, 1 H), 7.57 (s, 1 
H), 2.36 (s, 3 H), 2.21 (s, 3 H).  
NaOH, NBS, 
CHCl3, rt, 16 h
(78%)
2.44
HO
O
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13C NMR (150 MHz, DMSO-d6) δ: 193.3, 184.0, 178.9, 171.2, 158.7, 139.8, 130.8, 129.0, 
128.0, 124.4, 117.3, 24.4, 17.3. 
HRMS (ESI) calcd for C13H10BrNO4 [M-H]–: 321.9720; found: 321.9723. 
 
 
 
Aminonaphthoquinone 2.49: 
Bromo-naphthoquinone 2.48 (103 mg, 0.32 mmol, 1.0 equiv.) was dissolved in dry CH2Cl2 
(15 mL) and the clear yellow solution was cooled to 0 °C. DIPEA (111 µL, 0.64 mmol, 2.0 
equiv.) was added dropwise, upon which the solution rapidly turned purple. Bromomethyl 
methyl ether (34 µL, 0.41 mmol, 1.3 equiv.) was added dropwise and the resulting yellow 
solution was warmed to rt and stirred for 30 min. Sat. aq. NaHCO3 (10 mL) was then added 
and the layers separated. The aqueous layer was extracted with CHCl3 (3 × 15 mL), the 
combined organics were dried over sodium sulfate, filtered and the solvent was removed 
under reduced pressure. Purification of the residue by flash column chromatography (silica 
gel, CHCl3:acetone = 20:1) afforded MOM-ether 2.49 (117 mg, 0.32 mmol, 100%) as a 
yellow solid. 
TLC (CHCl3:acetone = 10:1), Rf = 0.73  (UV/CAM)  
M.p.: 117 °C 
1H NMR (300 MHz, CDCl3) δ: 8.22 (br s, 1 H), 8.00 (d, J = 0.7 Hz, 1 H), 7.80 (s, 1 H), 5.18 
(s, 2 H), 3.67 (s, 3 H), 2.50 (d, J = 0.7 Hz, 3 H), 2.27 (s, 3 H).  
13C NMR (75 MHz, CDCl3) δ: 183.6, 179.9, 169.2, 160.6, 138.6, 138.2, 129.8, 129.1, 128.2, 
119.0, 118.1, 100.4, 58.1, 25.0, 17.9. 
IR (Diamond-ATR, neat) νmax: 3292, 3100, 2924, 1719, 1671, 1638, 1585, 1528, 1338, 1276, 
1257, 1226, 1158, 1076, 1020, 971, 912, 798, 750, 732 cm-1. 
HRMS (ESI) calcd for C15H14BrNO5 [M+H]+: 368.0128; found: 368.0131. 
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30 min
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Hydroquinone dimethyl ether 2.37: 
MOM-ether 2.49 (200 mg, 543 µmol, 1.0 equiv.) was dissolved in a 2:1 mixture of THF (20 
mL) and water (10 mL) and Cerium(III)-chloride heptahydrate (304 mg, 0.81 mmol, 1.50 
equiv.) was added. The reaction mixture was cooled to 0 °C and NaBH4 (41 mg, 1.09 mmol, 
2.0 equiv.) was added in two portions over 5 min. After 15 min, a solution of KOH (610 mg, 
10.9 mmol, 20 equiv.) in H2O (13 mL) was added to the clear solution. The resulting brown 
reaction mixture was stirred for 15 min and Me2SO4 (1.55 mL, 16.3 mmol, 30 equiv.) was 
next added dropwise. After 2 h, conc. NH4OH (10 mL) and H2O (20 mL) were added, the 
reaction mixture was warmed to rt and extracted with EtOAc (3 × 50 mL) and CHCl3 (3 × 20 
mL). The combined organic layers were dried over sodium sulfate, filtered and concentrated 
under reduced pressure. Purification of the residue by flash column chromatography (silica 
gel, CHCl3:acetone = 20:1) afforded the title compound 2.37 (209 mg, 0.52 mmol, 97%) as a 
beige solid.  
TLC (CHCl3:acetone = 10:1), Rf = 0.5 (UV/CAM)  
M.p.: 168 °C 
1H NMR (300 MHz, CDCl3) δ: 8.06 (s, 1 H), 7.78 (br s, 1 H), 7.72 (s, 1 H), 5.16 (s, 2 H), 
3.95 (s, 3 H), 3.83 (s, 3 H), 3.68 (s, 3 H), 2.53 (d, J = 0.9 Hz, 3 H), 2.27 (s, 3 H).  
13C NMR (75 MHz, CDCl3) δ: 168.5, 152.8, 152.4, 135.6, 133.1, 127.8, 127.1, 122.2, 120.8, 
111.9, 101.5, 100.1, 61.5, 57.8, 56.0, 25.0, 18.4. 
IR (Diamond-ATR, neat) νmax: 3233, 2947, 1662, 1621, 1607, 1572, 1529, 1458, 1401, 1369, 
1319, 1272, 1241, 1224, 1150, 1099, 1073, 1037, 998, 981, 962, 919, 878, 827, 786, 759, 733, 
702, 677 cm-1. 
HRMS (ESI) calcd for C17H20BrNO5 [M+H]+: 398.0603; found: 398.0602. 
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tert-Butyl (2,5-dimethoxyphenyl)carbamate (2.51) 
To a solution of 2,5-dimethoxyaniline (2.50) (20 g, 163 mmol, 1.0 equiv.) in dry THF (100 
mL) was added Boc2O (34.2 g, 196 mmol, 1.2 equiv.) and the black reaction mixture was 
heated under reflux for 12 h. After cooling to rt, the solvent was evaporated in vacuo and the 
crude product was purified by flash column chromatography (silica gel, gradient: 
hexanes:EtOAc = 10:1 → 5:1) to afford the product 2.51 (38.6 g, 153 mmol, 94%) as a 
viscous light yellow oil. 
TLC (hexanes:EtOAc = 5:1), Rf = 0.38 (UV/CAM)  
1H NMR (300 MHz, CDCl3) δ: 7.79 (s, 1 H), 7.09 (s, 1 H), 6.76 (d, J = 8.9 Hz, 1 H), 6.49 
(dd, J = 8.9, 3.0 Hz, 1 H), 3.82 (s, 3 H), 3.78 (s, 3 H), 1.53 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ = 154.1, 152.6, 141.7, 128.9, 110.8, 107.1, 104.3, 80.3, 56.2, 
55.8, 28.4.  
HRMS (EI) calcd for C13H19NO4 [M]+•: 253.1314; found: 253.1304. 
 
 
 
2-tert-Butoxycarbonylamino-1,4-benzoquinone (2.52) 
To a solution of 2.51 (1.0 g, 3.95 mmol, 1.0 equiv.) in a mixture of water (20 mL) and MeOH 
(0.5 mL) was added PhI(OAc)2 (3.18 g, 5.93 mmol, 2.5 equiv.) and the resulting suspension 
was stirred for 3 h at rt. Water (60 mL) was added and the mixture was extracted with CH2Cl2 
(3 × 40 mL). The combined organic layers were washed with water (120 mL), dried over 
sodium sulfate, filtered and concentrated in vacuo. The resulting dark-brown residue was 
purified by flash column chromatography (silica gel, gradient: hexanes:EtOAc = 20:1 → 
15:1) to afford the product 2.52 (393 mg, 1.76 mmol, 45%) as a yellow solid 
Note: When the reaction was scaled up to 20 g, the yield dropped to 19%. 
TLC (hexanes:EtOAc = 1:1), Rf = 0.77 (UV/CAM)  
1H NMR (300 MHz, CDCl3) δ: 7.38 (br s, 1 H), 7.21 (d, J = 2.2 Hz, 1 H), 6.73 (s, 1 H), 6.72 
(d, J = 2.1 Hz, 1 H), 1.51 (s, 9 H).  
Boc2O, THF
reflux, 12 h
(94%)
2.50
OMe
OMe
NH2
2.51
OMe
OMe
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H2O/MeOH
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13C-NMR (75 MHz, CDCl3) δ = 187.4, 182.4, 151.0, 139.3, 138.2, 133.1, 112.5, 82.7, 28.1.  
HRMS (EI) calcd for C11H13NO [M]+•: 223.0845; found: 223.0837. 
 
 
 
Boc-aminonaphthoquinone 2.53: 
A pressure tube was charged with diene 2.42 (1.31 g, 7.0 mmol, 1.0 equiv), Boc-quinone 2.52 
(1.56 g, 7.0 mmol, 1.0 equiv.) and dry benzene (10 mL), sealed and heated to 75 °C for 3 h. 
The yellow reaction mixture was cooled to rt and washed with HCl (1 M, 10 mL). The 
organic layer was separated, dried over sodium sulfate, filtered and the solvent was removed 
under reduced pressure. The crude residue was dissolved in a 1:1 mixture of CHCl3 (25 mL) 
and acetone (25 mL) and oven-dried silica gel (5 g) was added. The suspension was stirred 
under ambient atmosphere for 24 h and subsequently concentrated under reduced pressure. 
The crude material was purified by flash column chromatography (silica gel, dry load, 
gradient: CHCl3:acetone = 30:1 → 10:1 → 5:1 → 2:1 → 1:1) to afford the product 2.53 (1.48 
g, 4.88 mmol, 77%) as an orange solid. 
TLC (CHCl3:acetone = 20:1), Rf = 0.26 (visible/CAM)  
M.p.: 320 °C (decomp.)  
1H NMR (400 MHz, DMSO-d6) δ: 11.07 (s, 1 H), 8.51 (s, 1 H), 7.77 (d, J = 0.8 Hz, 1 H), 
7.30 (s, 1 H), 7.11 (s, 3 H), 2.22 (d, J = 0.5 Hz, 3 H), 1.48 (s, 9 H).  
13C NMR (100 MHz, DMSO-d6) δ: 184.4, 178.5, 161.8, 151.5, 141.8, 131.9, 130.2, 129.6, 
121.7, 113.3, 110.7, 81.7, 27.7, 15.9.  
IR (Diamond-ATR, neat) νmax: 3326, 1737, 1664, 1632, 1609, 1578, 1496, 1335, 1225, 1202, 
1143, 1079, 1042, 1014, 962, 915, 876, 810, 802, 768, 736 cm-1. 
HRMS (ESI) calcd for C16H17NO5 [M+H]+: 304.1179; found: 304.1181. 
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Bromo-aminonaphthoquinone 2.54: 
To a solution of Boc-protected aminonaphthoquinone 2.53 (1.20 g, 3.94 mmol, 1.0 equiv.) in 
CHCl3 (300 mL) was added N-Bromosuccinimide (841 mg, 4.72 mmol, 1.2 equiv.) and the 
orange reaction mixture was stirred at rt for 30 min. The solvent was evaporated in vacuo and 
the crude product was purified by flash column chromatography (silica gel packed in CHCl3, 
gradient: hexanes:EtOAc = 10:1 → 5:1 → 2:1) to provide the target compound 2.54 (1.36 g, 
3.56 mmol, 90%) as a yellow solid. 
TLC (CHCl3:acetone = 10:1), Rf = 0.78  (visible/UV/CAM)  
M.p.: 173 °C 
1H NMR (300 MHz, CDCl3) δ: 7.93 (s, 1 H), 7.64 (s, 1 H), 7.38 (s, 1 H), 7.02 (s, 1 H), 2.41 
(s, 3 H), 1.53 (s, 9 H).  
13C NMR (75 MHz, CDCl3) δ: 183.3, 179.2, 156.9, 151.2, 139.7, 130.0, 129.7, 127.8, 124.9, 
115.6, 109.1, 82.6, 28.1, 17.1. 
IR (Diamond-ATR, neat) νmax: 3376, 2983, 1740, 1657, 1647, 1622, 1581, 1507, 1457, 1327, 
1271, 1231, 1206, 1181, 1144, 1094, 1042, 1011, 967, 886, 867, 816, 680 cm-1. 
HRMS (ESI) calcd for C16H15BrNO5 [M-H]–: 380.0139; found: 380.0141. 
 
 
 
MOM-aminonaphthoquinone 2.55: 
Bromo-naphthoquinone 2.54 (1.32 g, 3.46 mmol, 1.0 equiv.) was dissolved in dry CH2Cl2 
(100 mL) and the clear orange solution was cooled to 0 °C. DIPEA (1.21 mL, 6.92 mmol, 2.0 
equiv.) was added dropwise, upon which the solution rapidly turned dark purple. 
Bromomethyl methyl ether (367 µL, 4.50 mmol, 1.3 equiv.) was added dropwise and the 
reaction mixture was allowed to stir for 45 min at 0 °C. Sat. aq. NaHCO3 (50 mL) was then 
added and the layers separated. The aqueous layer was extracted with CHCl3 (3 × 100 mL), 
the combined organics were dried over sodium sulfate, filtered and the solvent was removed 
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under reduced pressure. Purification of the residue by flash column chromatography (silica 
gel, gradient: CHCl3:acetone = 40:1 → 30:1) afforded MOM-ether 2.55 (1.40 g, 3.29 mmol, 
95%) as a yellow solid. 
TLC (CHCl3:acetone = 20:1), Rf = 0.63  (UV/CAM)  
M.p.: 42 °C 
1H NMR (300 MHz, CDCl3) δ: 7.99 (d, J = 0.7 Hz, 1 H), 7.59 (br s, 1 H), 7.43 (s, 1 H), 5.18 
(s, 2 H), 3.67 (s, 3 H), 2.49 (d, J = 0.7 Hz, 3 H), 1.53 (s, 9 H).  
13C NMR (75 MHz, CDCl3) δ: 183.2, 179.6, 160.5, 151.2, 139.3, 138.4, 129.7, 129.1, 128.4, 
118.0, 116.7, 100.4, 82.6, 58.0, 28.1, 17.9. 
IR (Diamond-ATR, neat) νmax: 3384, 2977, 2931, 1735, 1666, 1646, 1629, 1582, 1501, 1454, 
1392, 1368, 1327, 1271, 1239, 1208, 1140, 1100, 1078, 1040, 1005, 971, 918, 884, 864, 804, 
751, 726 cm-1. 
HRMS (ESI) calcd for C18H21BrNO6 [M+H]+: 426.0547; found: 426.0549. 
 
 
 
Hydroquinone dimethyl ether 2.56: 
MOM-ether 2.55 (1.40 g, 3.29 mmol, 1.0 equiv.) was dissolved in a 2:1 mixture of THF (80 
mL) and water (40 mL) and Cerium(III)-chloride heptahydrate (1.80 g, 4.94 mmol, 1.50 
equiv.) was added. The reaction mixture was cooled to 0 °C and NaBH4 (250 mg, 6.58 mmol, 
2.0 equiv.) was added in two portions over 5 min. After 20 min, a solution of KOH (3.70 g, 
65.8 mmol, 20 equiv.) in H2O (15 mL) was added dropwise to the white reaction mixture 
which turned immediately black-brown. Me2SO4 (9.3 mL, 98.7 mmol, 30 equiv.) was next 
added dropwise and the resulting solution was stirred at 0 °C for 35 min, after which conc. 
NH4OH (50 mL) and H2O (15 mL) were added. The reaction mixture was warmed to rt, 
extracted with EtOAc (3 × 250 mL) and the combined organic layers were dried over sodium 
sulfate, filtered and concentrated under reduced pressure. Purification of the residue by flash 
column chromatography (silica gel, gradient: hexanes:EtOAc = 20:1 → 10:1→ 5:1) afforded 
the title compound 2.38 (1.33 g, 2.92 mmol, 89%) as an off-white solid.  
TLC (hexanes:EtOAc = 2:1), Rf = 0.77 (UV/CAM)  
M.p.: 100 °C 
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1H NMR (600 MHz, CDCl3) δ: 7.87 (br s, 1 H), 7.70 (d, J = 1.0 Hz, 1 H), 7.11 (br s, 1 H), 
5.16 (s, 2 H), 3.96 (s, 3 H), 3.82 (s, 3 H), 3.68 (s, 3 H), 2.53 (d, J = 0.9 Hz, 3 H), 1.56 (s, 9 H).  
13C NMR (150 MHz, CDCl3) δ: 152.7, 152.5, 152.3, 134.8, 133.0, 128.2, 127.3, 122.0, 120.0, 
111.8, 100.5, 100.1, 80.9, 61.3, 57.8, 56.0, 28.4, 18.4. 
IR (Diamond-ATR, neat) νmax: 3308, 2977, 2928, 1718, 1626, 1614, 1573, 1512, 1448, 1362, 
1315, 1264, 1243, 1221, 1148, 1112, 1043, 984, 940, 916, 874, 830, 783, 769, 761, 669 cm-1. 
HRMS (EI) calcd for C20H26BrNO6 [M]+•: 455.0944; found: 455.0942. 
 
 
 
Di-Boc-naphthalene 2.56: 
To a solution of hydroquinone dimethyl ether 2.38 (32 mg, 0.07 mmol, 1.0 equiv.) in dry 
CH3CN (3 mL) was added Boc2O (23 mg, 0.11 mmol, 1.5 equiv.) and DMAP (11 mg, 0.09 
mmol, 1.3 equiv.) and the reaction mixture was stirred at rt for 24 h. Sat. aq. NaHCO3 (2 mL) 
was added and the reaction mixture was extracted with CHCl3 (3 × 10 mL). The combined 
organics were dried over sodium sulfate, filtered and concentrated in vacuo. Purification of 
the residue by flash column chromatography (silica gel, gradient: hexanes:EtOAc = 15:1 → 
7:1) afforded the title compound 2.56 (22 mg, 39.5 µmol, 56%) as a colourless wax. 
TLC (hexanes:EtOAc = 5:1), Rf = 0.37 (UV/CAM)  
1H NMR (400 MHz, CDCl3) δ: 7.89 (d, J = 1.0 Hz, 1 H), 6.60 (s, 1 H), 5.18 (s, 2 H), 3.90 (s, 
3 H), 3.83 (s, 3 H), 3.69 (s, 3 H), 2.54 (d, J = 0.8 Hz, 3 H), 1.41 (s, 18 H). 
13C NMR (100 MHz, CDCl3) δ: 154.0, 151.8, 151.5, 144.1, 132.8, 128.1, 127.9, 123.9, 123.7, 
111.6, 108.1, 100.1, 82.7, 61.4, 57.9, 56.2, 27.9, 18.4. 
IR (Diamond-ATR, neat) νmax: 3428, 2980, 2936, 2254, 1782, 1747, 1711, 1622, 1606, 1573, 
1458, 1409, 1392, 1369, 1319, 1276, 1252, 1150, 1101, 1046, 984, 947, 852, 751, 733, 666 
cm-1. 
HRMS (ESI) calcd for C25H34BrNO8Na [M+Na]+: 578.1360; found: 578.1371. 
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(Z)-3-iodo-2-methylprop-2-en-1-ol (2.58) 
To a suspension of copper(I)-iodide (1.90 g, 10 mmol, 0.1 equiv.) in dry THF (160 mL) was 
added propargyl alcohol (2.57) (5.61 g, 100 mmol, 1.0 equiv.) and the resulting white 
suspension was cooled to -35 °C. Methylmagnesium bromide (3 M solution in Et2O, 84 mL, 
2.5 equiv.) was added by syringe pump over 2 h and the mixture was warmed to rt and stirred 
for 16 h. Then, the dark-grey reaction mixture was cooled to -78 °C and a solution of iodine 
(28 g, 110 mmol, 1.1 equiv.) in dry THF (80 mL) was added via cannula over 20 min. The 
reaction mixture was warmed to rt, stirred for 14 h and then quenched with sat. aq. solution of 
NH4Cl (150 mL). The layers were separated and the aq. layer was extracted with Et2O 
(3 × 150 mL). The combined org. extracts were dried over sodium sulfate, filtered and 
concentrated in vacuo and the resulting crude was purified by flash column chromatography 
(silica gel, hexanes:EtOAc = 4:1) to give allylic alcohol 2.58 (13 g, 65.6 mmol, 66%) as a 
brown oil. 
TLC (hexanes:EtOAc = 4:1), Rf = 0.32 (UV/KMnO4)  
1H NMR (200 MHz, CDCl3) δ: 5.99–5.97 (m, 1 H), 4.25 (s, 2 H), 1.99–1.98 (m, 3 H).  
 
 
 
(Z)-3-iodo-2-methylacrylic acid (2.22) 
To a solution of alcohol 2.58 (2.0 g, 10.1 mmol, 1.0 equiv.) in dry CH2Cl2 (200 mL) was 
added manganese dioxide (17.6 g, 202 mmol, 20 equiv.) at rt. The resulting mixture was 
stirred for 16 h and filtered over a pad of Celite. Careful concentration (500 mbar/40 °C water 
bath) of the collected filtrate gave sensitive aldehyde 2.59 (2.0 g, 10.2 mmol, quant.), which 
was directly used in the next step without further purification.  
Crude aldehyde 2.59 (2.0 g, 10.2 mmol, 1.0 equiv.) was dissolved in CH3CN (12 mL) and a 
solution of NaH2PO4·H2O (424 mg, 3.07 mmol, 0.3 equiv.) in water (8 mL) was added. The 
mixture was cooled to 0 °C and H2O2 (14 mL) was added. Then, a solution of NaClO2 (1.6 g, 
17.7 mmol, 1.7 equiv.) was added dropwise and the reaction mixture was stirred at 0 °C for 1 
HO
I
HO
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-35 °C → rt, 16 h
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h before being warmed to rt. After 2 h, the mixture was extracted with Et2O (3 × 25 mL), the 
aq. layer was acidified with 2 M HCl and extracted with Et2O (3 × 25 mL). The combined 
org. layers were dried over sodium sulfate, filtered and concentrated to afford a light yellow 
liquid. Purification of the crude product by flash column chromatography (silica gel, 
pentane:Et2O = 1:1) afforded vinyl iodide 2.22 (1.55 g, 7.3 mmol, 71%) as a colourless liquid 
which solidified in the freezer. 
TLC (hexanes:EtOAc:AcOH = 1:1:0.01), Rf = 0.36 (UV/KMnO4)  
1H NMR (400 MHz, CDCl3) δ: 7.12 (q, J = 1.5 Hz, 1 H), 2.11 (d, J = 1.6 Hz, 3 H).  
13C-NMR (100 MHz, CDCl3) δ = 171.7, 137.7, 86.3, 22.4.  
HRMS (EI) calcd for C4H5IO2 [M]+•: 211.9334; found: 211.9331. 
3.3.2 Divergolides C and D Project 
 
3,6-Dihydro-2H-pyran (2.74): 
Tetrahydro-4H-pyran-4-one (2.72) (2.5 g, 25 mmol, 1.0 equiv.) was dissolved in dry THF (13 
mL) and cooled to 0 °C. In a separate flask, LiAlH4 (1.9 g, 50 mmol, 2.0 equiv.) was 
suspended in dry THF (25 mL) and the slurry was slowly transferred via cannula to the flask 
containing pyranone 2.72. The reaction mixture was stirred for 3.5 h at 0 °C and subsequently 
quenched by addition of water (2 mL) and NaOH (3 M, 2 mL). The suspension was filtered 
through Celite and the filter cake was washed with EtOAc (2 × 70 mL). The filtrate was 
concentrated in vacuo to give crude alcohol 2.73 (2.25 g, 22.0 mmol, 88%), which was used 
in the next step of the reaction sequence without further purification.  
To a solution of the crude pyranol 2.73 (2.25 g, 22.0 mmol, 1.0 equiv.) in dry CH2Cl2 (45 mL) 
was added triethylamine (3.69 mL, 26.4 mmol, 1.2 equiv.) and the clear solution was cooled 
to 0 °C. Methanesulfonyl chloride (1.86 mL, 24.0 mmol, 1.09 equiv.) was then added 
dropwise and the resulting cloudy mixture was stirred at 0 °C for 1 h, warmed to rt and stirred 
for another 2 h, before water (40 mL) was added. The organic layer was separated, dried over 
sodium sulfate, filtered and concentrated under reduced pressure. To the yellow crude 
mesylate was transferred to a flask fitted for distillation and then DBU (3.75 mL) was added. 
The flask reaction mixture was slowly heated to 140 °C and the material boiling at 68-70 °C 
was collected to provide pyran 2.74 (1.24 g, 14.7 mmol, 67%) as a volatile, colorless liquid.  
TLC (hexanes:EtOAc = 2:1), Rf = 0.67 (KMnO4) 
1) MsCl, Et3N, CH2Cl2 
    0 °C  rt, 2 h
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1H NMR (400 MHz, CD2Cl2) δ: 5.85–5.80 (m, 1 H), 5.72–5.68 (m, 1 H), 4.08–4.05 (m, 2 H), 
3.73 (t, J = 5.5 Hz, 2 H), 2.12–2.06 (m, 2 H).  
13C NMR (100 MHz, CD2Cl2) δ: 127.1, 124.7, 65.7, 64.6, 25.8.  
HRMS (EI) calcd for C5H8O [M]+•: 84.0575; found: 84.0568. 
 
 
 
(R)-3-Vinyl-pentan-1-ol (2.71): 
A Schlenk flask was charged with the catalyst (R)-[(EBTHI)]ZrCl2 (37.0 mg, 86.7 µmol, 0.1 
equiv.), dry THF (1 mL) and EtMgCl (2 M solution in THF, 2.6 mL, 5.2 mmol, 5.8 equiv.) 
and the resulting yellow solution was stirred under argon at rt for 45 min. In a separate flask, 
EtMgCl (2 M solution in THF, 0.45 mL, 0.9 mmol, 1.0 equiv.) was added to a solution of 3,4-
dihydropyran (2.74) (76.0 mg, 0.90 mmol, 1.0 equiv.) in dry THF (0.4 mL). The latter 
solution was next transferred to the solution containing the Zr-catalyst via cannula and the 
solution was stirred at rt. After 16 h, the reaction mixture was cooled to 0 °C and quenched by 
dropwise addition of aq. HCl (0.1 M, 2 mL). Water (10 mL) and CH2Cl2 (15 mL) were added 
and the mixture was filtered over a short plug of Celite. The organic layer of the filtrate was 
separated, dried over sodium sulfate, filtered and concentrated in vacuo. Purification of the 
yellow crude product by flash column chromatography (silica gel, hexanes:EtOAc = 2:1) 
afforded the title compound 2.71 (43.1 mg, 0.38 mmol, 42%) as a colorless liquid.  
TLC (hexanes:EtOAc = 2:1), Rf = 0.42 (KMnO4) 
1H NMR (600 MHz, CDCl3) δ: 5.59–5.53 (m, 1 H), 5.03–5.02 (m, 1 H), 5.01–5.00 (m, 1 H), 
3.70–3.61 (m, 2 H), 2.07–2.01 (m, 1 H), 1.71–1.65 (m, 1 H), 1.53–1.47 (m, 1 H), 1.45–1.39 
(m, 1 H), 1.32–1.25 (m, 1 H), 0.86 (t, J = 7.4 Hz, 3 H).   
13C-NMR (75 MHz, CDCl3) δ = 142.7, 114.9, 61.4, 42.9, 37.5, 27.9, 11.5. 
IR (Diamond-ATR, neat) νmax: 3324, 2961, 2923, 2875, 1641, 1455, 1420, 1379, 1292, 1237, 
1201, 1057, 1023, 995, 910, 874, 734, 675 cm-1. 
HRMS (EI) calcd for C7H14O [M]+•: 114.1045; found: 114.1043.  
[α]25D = –12.4° (c = 0.5, CHCl3) 
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Enone 2.76: 
A solution of (S)-4-isopropyloxazolidin-2-one (2.75) (3.31 g, 25.6 mmol, 1.0 equiv.) in dry 
THF (80 mL) was cooled to -78 °C and n-BuLi (2.5 M in hexanes, 10.4 mL, 25.9 mmol, 1.03 
equiv.) was added dropwise over 10 min. Then, (E)-pent-2-enoyl chloride48 (3.34 g, 28.2 
mmol, 1.1 equiv.) was added in one portion and the resulting yellow solution was continued 
to be stirred at -78 °C. After 40 min, the reaction mixture was warmed to rt over 20 min and 
subsequently quenched by addition of sat. aq. solution of NH4Cl (25 mL). The volatiles (THF 
and hexanes) were removed under reduced pressure and the residue was extracted with 
CH2Cl2 (3 × 50 mL). The combined organics were washed with NaOH (1 M, 75 mL), sat. aq. 
NaCl (100 mL), dried over sodium sulfate, filtered and concentrated in vacuo. Purification of 
the crude yellow oil by flash column chromatography (silica gel, hexanes:EtOAc = 10:1) 
afforded the title compound 2.76 (5.15 g, 24.4 mmol, 95%) as a white solid. 
TLC (hexanes:EtOAc = 10:1), Rf = 0.19  (UV/KMnO4)  
1H NMR (600 MHz, CDCl3) δ: 7.26 (dt, J = 15.4, 1.4 Hz, 1 H), 7.18 (dt, J = 15.4, 6.2 Hz, 1 
H), 4.49 (ddd, J = 8.3, 3.9, 3.1 Hz, 1 H), 4.29–4.26 (m, 1 H), 4.21 (dd, J = 9.1, 3.1 Hz, 1 H), 
2.45–2.37 (m, 1 H), 2.30 (qdd, J = 7.5, 6.2, 1.4 Hz, 2 H), 1.10 (t, J = 7.4 Hz, 3 H), 0.92 (d, J = 
7.1 Hz, 3 H), 0.88 (d, J = 6.9 Hz, 3 H).  
13C NMR (150 MHz, CDCl3) δ: 165.2, 154.1, 152.8, 119.6, 63.3, 58.5, 28.5, 25.8, 18.0, 14.7, 
12.2. 
IR (Diamond-ATR, neat) νmax: 2966, 2935, 2877, 1770, 1681, 1635, 1487, 1466, 1386, 1363, 
1349, 1298, 1260, 1199, 1146, 1121, 1096, 1062, 1042, 1016, 974, 858, 773, 752, 713, 665 
cm-1. 
HRMS (EI) calcd for C11H17NO3 [M]+•: 211.1208; found: 211.1189. 
[α]25D = +100.4° (c = 0.5, CHCl3) 
 
 
 
O NH
O
2.75
1) n-BuLi, THF, -78 °C
2)
(96%)
Cl
O
, THF
-78 °C, 40 min O N
O O
2.76
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Imide 2.77: 
To a suspension of CuBr⋅SMe2 (2.92 g, 14.2 mmol, 1.5 equiv.) and 4 Å mol sieves in dry 
THF (100 mL) in a Schlenk flask was added dimethyl sulfide (38 mL) at rt. The solution was 
cooled to -48 °C and vinylmagnesium bromide (31.6 mL, 28.4 mmol, 3.0 equiv.) was added. 
After 10 min stirring at -23 °C, a solution of enone 2.76 (2.0 g, 9.48 mmol, 1.0 equiv.) in dry 
THF (40 mL) was added and the whole was stirred at this temperature for 1 h. Then, the 
reaction was quenched with sat. aq. solution of NH4Cl (100 mL) and warmed to rt. The 
reaction mixture was filtered through a pad of Celite, and the filtrate was extracted with 
EtOAc (3 × 100 mL). The combined organic layers were washed with sat. aq. NaCl (250 mL), 
dried over sodium sulfate, filtered and concentrated in vacuo. The yellow residue was purified 
by flash column chromatography (silica gel, hexanes:EtOAc = 15:1) to provide product 2.77 
(2.09 g, 8.76 mmol, 92%) as a 2:1 mixture of diastereomers. 
TLC (hexanes:EtOAc = 5:1), Rf = 0.39 (KMnO4)  
Major diastereomer: 
1H NMR (300 MHz, CDCl3) δ: 5.67 (ddd, J = 17.2, 10.3, 8.5 Hz, 1 H), 5.06–4.98 (m, 2 H), 
4.45–4.40 (m, 1 H), 4.27–4.16 (m, 2 H), 3.14 (dd, J = 15.6, 8.5 Hz, 1 H), 2.89 (dd, J = 16.2, 
7.4 Hz, 1 H), 2.57–2.49 (m, 1 H), 2.40–2.28 (m, 1 H), 1.53–1.31 (m, 3 H), 0.90 (d, J = 7.2 Hz, 
3 H), 0.85 (d, J = 6.9 Hz, 3 H). 
13C NMR (75 MHz, CDCl3) δ: 172.2, 154.0, 140.9, 115.2, 63.2, 58.5, 41.9, 40.0, 28.3, 27.5, 
18.0, 14.6, 11.5. 
HRMS (EI) calcd for C13H21NO3 [M]+•: 239.1521; found: 239.1507. 
 
 
 
Acid 2.78: 
A solution of imide 2.77 (280 mg, 1.17 mmol, 1.0 equiv.) in THF (16 mL) and water (5 mL) 
was cooled to 0 °C and H2O2 (6.5 mL) added. The mixture was stirred at this temperature for 
2 min, LiOH⋅H2O (97 mg, 2.31 mmol, 2.0 equiv.) was added and the reaction mixture was 
O N
O O
(92%)
O N
O OMgBr
CuBr⋅SMe2, THF
2.76 2.77
O N
O O
2.77
H2O2, LiOH
THF/H2O
(93%)
O
HO
2.78
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warmed to rt. After 24 h, the solution was cooled back to 0 °C and aq. sodium sulfite solution 
(1.5 M, 3.5 mL) was added. Stirring was continued for 1 h, before THF was removed in under 
reduced pressure. The residue was extracted with CH2Cl2 (2 × 10 mL), the aqueous layer was 
acidified to pH = 1 with aq. HCl (1 M) and then extracted extensively extracted with CH2Cl2 
and EtOAc until TLC indicated that no more product was left in the aqueous phase. The 
combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. 
The residue was purified by flash column chromatography (silica gel, hexanes:Et2O = 2:1) to 
give the title compound 2.78 (140 mg, 1.09 mmol, 93%) as a colorless liquid. 
TLC (hexanes:EtOAc = 1:1), Rf = 0.52 (KMnO4)  
1H NMR (400 MHz, CD2Cl2) δ: 5.65 (ddd, J = 17.2, 10.3, 7.8 Hz, 1 H), 5.08–5.02 (m, 2 H), 
2.44–2.40 (m, 2 H), 2.36–2.32 (m, 1 H), 1.54–1.43 (m, 1 H), 1.39–1.32 (m, 1 H), 0.89 (t, J = 
7.4 Hz, 3 H).  
13C NMR (100 MHz, CD2Cl2) δ: 178.2, 141.1, 115.4, 42.2, 39.6, 27.6, 11.6. 
IR (Diamond-ATR, neat) νmax: 2963, 2926, 2877, 1704, 1642, 1420, 1410, 1285, 1256, 1228, 
1199, 1139, 1110, 1072, 1035, 993, 915, 771, 670 cm-1. 
HRMS (EI) calcd for C7H12O2 [M]+•: 128.0837; found: 128.0826. 
 
 
 
Alcohol 2.79: 
To a solution of acid 2.78 (736 mg, 5.74 mmol, 1.0 equiv.) in dry THF (20 mL) was added 
LiAlH4 (436 mg, 11.5 mmol, 2.0 equiv.) at 0 °C. The reaction mixture was warmed to rt, 
stirred for 1.5 h and then refluxed for another 2 h. Then, the mixture was cooled to rt, 
quenched by addition of aq. NaOH (1 M, 10 mL) and extracted with Et2O and CH2Cl2 until 
no more product was detectable in the aqueous layer by TLC. The combined organic extracts 
were dried over sodium sulfate, filtered and concentrated under reduced pressure to give the 
title compound 2.79 (606 mg, 5.31 mmol, 93%) as a colorless, volatile liquid. 
TLC (hexanes:EtOAc = 2:1), Rf = 0.41 (KMnO4)  
1H NMR (300 MHz, CDCl3) δ: 5.63–5.50 (m, 1 H), 5.05–5.03 (m, 1 H), 5.00–4.98 (m, 1 H), 
3.70–3.60 (m, 2 H), 2.10–1.98 (m, 1 H), 1.73–1.63 (m, 1 H), 1.55–1.36 (m, 3 H), 1.33–1.21 
(m, 1 H), 0.86 (t, J = 7.4 Hz, 3 H).  
13C NMR (75 MHz, CDCl3) δ: 142.7, 114.9, 61.3, 42.9, 37.5, 27.9, 11.5. 
O
HO
2.78
LiAlH4, THF
reflux, 2 h
(93%) HO
2.79
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IR (Diamond-ATR, neat) νmax: 3324, 2961, 2923, 2875, 1641, 1455, 1420, 1379, 1292, 1237, 
1201, 1057, 1023, 995, 910, 874, 734, 675 cm-1. 
HRMS (EI) calcd for C7H14O [M]+•: 114.1045; found: 114.1043. 
[α]25D = –5.4° (c = 0.5, CHCl3) 
 
 
 
(R)-5-((trityloxy)methyl)pyrrolidin-2-one (2.81) 
To a solution of (R)-5-(hydroxymethyl)pyrrolidin-2-one (2.80) (8.04 g, 69.9 mmol, 1.0 
equiv.) in dry CH2Cl2 (600 mL) was added triethylamine (14.6 mL, 104.9 mmol, 1.5 equiv.), 
DMAP (1.1 g, 9.1 mmol, 0.13 equiv.) and trityl chloride (29.2 g, 104.9 mmol, 1.5 equiv.) and 
the solution was stirred at rt for 12 h. The reaction mixture was washed with water (3 × 250 
mL) and sat. aq. NaCl (3 × 250 mL) and the combined organic layers were dried over sodium 
sulfate, filtered and concentrated under reduced pressure. Purification of the residue by flash 
column chromatography (silica gel, gradient: CH2Cl2:MeOH = 50:1 → 40:1 → 10:1 → 5:1) 
afforded the title compound 2.81 (16.7 g, 46.6 mmol, 67%) as a white solid. 
TLC (CHCl3:acetone = 10:1), Rf = 0.3 (UV/CAM) 
1H NMR (300 MHz, CDCl3) δ: 7.44–7.41 (m, 6 H), 7.35–7.24 (m, 9 H), 6.17 (br s, 1 H), 
3.91–3.83 (m, 1 H), 3.22 (dd, J = 9.3, 4.1 Hz, 1 H), 3.03 (dd, J = 9.3, 7.9 Hz, 1 H), 2.35–2.30 
(m, 2 H), 2.21–2.09 (m, 1 H), 1.74–1.62 (m, 1 H). 
13C-NMR (75 MHz, CDCl3) δ = 178.0, 143.6, 128.5, 127.9, 127.2, 86.8, 67.1, 54.1, 29.6, 
23.3. 
IR (Diamond-ATR, neat) νmax: 1687, 1489, 1447, 1323, 1284, 1211, 1157, 1082, 1029, 1003, 
900, 775, 760, 742, 704, 692 cm-1. 
HRMS (ESI) calcd for C24H24NO2 [M+H]+: 358.1802; found: 358.1802. 
[α]25D = –14.0° (c = 0.2, CHCl3) 
 
 
NH
O
OH
Ph3CCl, Et3N
DMAP, CH2Cl2
(67%)
NH
O
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2.80 2.81
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Enone 2.82: 
A Schlenk flask was charged with pyrrolidinone 2.81 (2.19 g, 6.13 mmol, 1.0 equiv.) and dry 
THF (25 mL). The solution was cooled to -78 °C and n-BuLi (2.5 M in hexanes, 2.48 mL, 
6.19 mmol, 1.01 equiv.) was added over 5 minutes. To the resulting slightly pink solution was 
next added (E)-pent-2-enoyl chloride48 (800 mg, 6.75 mmol, 1.1 equiv.) in one portion and 
stirring was continued at -78 °C for 40 minutes. The reaction mixture was then warmed to rt 
and quenched by addition of sat. aq. solution of NH4Cl (6 mL). The volatiles (THF and 
hexanes) were removed under reduced pressure and the residue was extracted with CH2Cl2 (3 
× 10 mL). The combined organics were washed with NaOH (1 M, 10 mL), sat. aq. NaCl (10 
mL), dried over sodium sulfate, filtered and concentrated in vacuo. Purification of the residue 
by flash column chromatography (silica gel, hexanes:EtOAc = 10:1) afforded the title 
compound 2.82 (2.05 g, 4.66 mmol, 76%) as a white fluffy solid. 
TLC (hexanes:EtOAc = 5:1), Rf = 0.47 (UV/CAM)  
1H NMR (600 MHz, CDCl3) δ: 7.37–7.35 (m, 6 H), 7.31 (dt, J = 15.4, 1.7 Hz, 1 H), 7.29–
7.26 (m, 6 H), 7.23–7.20 (m, 3 H), 7.13 (dt, J = 15.4, 6.5 Hz, 1 H), 4.56–4.51 (m, 1 H), 3.56 
(dd, J = 9.8, 4.0 Hz, 1 H), 3.15 (dd, J = 9.8, 2.7 Hz, 1 H), 2.96 (ddd, J = 17.9, 11.1, 9.9 Hz, 1 
H), 2.50 (ddd, J = 17.8, 9.9, 1.9 Hz, 1 H), 2.35–2.30 (m, 2 H), 2.12–2.05 (m, 1 H), 1.99–1.95 
(m, 1 H), 1.13 (t, J = 7.4 Hz, 3 H).  
13C NMR (150 MHz, CDCl3) δ: 176.4, 166.0, 151.9, 143.7, 128.5, 127.9, 127.1, 121.7, 87.0, 
64.1, 56.8, 33.4, 25.8, 21.2, 12.5. 
HRMS (ESI) calcd for C29H29NO3Na [M+Na]+: 462.2040; found: 462.2041. 
 
 
 
Imide 2.83: 
To a suspension of CuBr⋅SMe2 (105 mg, 0.51 mmol, 1.5 equiv.) and 4 Å mol sieves in dry 
THF (5 mL) in a Schlenk flask was added dimethyl sulfide (1.5 mL) at rt. The resulting light-
NH
O
OCPh3
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1) n-BuLi, THF, -78 °C
2)
(76%)
Cl
O
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-78 °C, 40 min N
O
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O
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O
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N
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brown solution was cooled to -48 °C and vinylmagnesium bromide (3.06 mL, 1.02 mmol, 3.0 
equiv.) was added in one portion. The resulting black solution was warmed to -23 °C and 
continued to be stirred for further 10 min, at which point a solution of enone 2.82 (150 mg, 
0.34 mmol, 1.0 equiv.) in dry THF (1.5 mL) was added. After 2.5 h at -23 °C, the reaction 
was quenched with sat. aq. solution of NH4Cl (5 mL) and warmed to rt. The mixture was 
extracted with EtOAc (3 × 25 mL) and the organic layers were combined, dried over sodium 
sulfate, filtered and concentrated in vacuo. The residue was purified by flash column 
chromatography (silica gel, gradient: hexanes:EtOAc = 8:1) to provide the target compound 
2.83 (152 mg, 0.33 mmol, 96%) as a single diastereomer (white solid). 
TLC (hexanes:EtOAc = 5:1), Rf = 0.52 (UV/CAM)  
1H NMR (400 MHz, CDCl3) δ: 7.41–7.38 (m, 6 H), 7.33–7.29 (m, 6 H), 7.27–7.22 (m, 3 H), 
5.71 (dd, J = 9.5, 7.7 Hz, 1 H), 5.05 (ddd, 16.8, 1.6, 0.8 Hz, 1 H), 5.01 (ddd, J = 10.3, 1.8, 0.6 
Hz, 1 H), 4.50–4.46 (m, 1 H), 3.57 (dd, J = 9.7, 4.0 Hz, 1 H), 3.19 (dd, J = 9.7, 2.6 Hz, 1 H), 
3.10–2.90 (m, 3 H), 2.59–2.52 (m, 1 H), 2.47 (ddd, J = 17.8, 9.8, 1.7 Hz, 1 H), 2.10–2.00 (m, 
1 H), 1.95–1.89 (m, 1 H), 1.56–1.48 (m, 1 H), 1.42–1.30 (m, 1 H), 0.91 (t, J = 7.4 Hz, 3 H).  
13C NMR (100 MHz, CDCl3) δ: 176.1, 172.6, 143.6, 141.2, 128.4, 127.8, 127.0, 114.8, 86.9, 
63.8, 56.6, 41.8, 41.1, 33.1, 27.3, 21.2, 11.5. 
IR (Diamond-ATR, neat) νmax: 3018, 2963, 1733, 1711, 1693, 1490, 1449, 1363, 1217, 1199, 
1087, 1029, 1002, 916, 901, 744, 705, 666 cm-1. 
HRMS (ESI) calcd for C31H33NO3Na [M+Na]+: 490.2353; found: 490.2353. 
[α]25D = +70.4° (c = 0.25, CHCl3) 
Experimental Part – NMR Spectra 
 172
3.4 NMR Spectra 
3.4.1 Naphthomycin K Project 
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3.5 Crystal Structures 
a) X-ray structure of Acetyl-aminonaphthoquinone 2.44: 
 
 
b) X-ray structure of MOM-Dibromo-naphthoquinone 2.47: 
 
 
c) X-ray structure of Acetyl-bromonaphthoquinone 2.48: 
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d) X-ray structure of Boc-aminonaphthoquinone 2.53: 
 
 
e) X-ray structure of Boc-bromoaminonaphthoquinone 2.54: 
 
 
f) X-ray structure of (Z)-3-iodo-2-methylacrylic acid (2.22): 
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Part III: Synthesis of Photochromic  
Open-Channel Blockers 
1 Introduction 
1.1 Optochemical Genetics 
Transmembrane proteins belong to nature´s most important molecular devices. They not only 
control the transport of specific substances into or out of a cell, but they also allow a cell to 
communicate with its environment, rendering it susceptible to a variety of input signals. As 
such, the ability to control transmembrane proteins could aid understanding and helping to 
cure diseases that are caused by a mal- or disfunction of these proteins. In recent years, a 
groundbreaking new approach towards this goal has emerged, called “optochemical 
genetics”.1 In essence, this method utilizes artificial photoreceptors or light-sensitive small 
molecules to control protein function or neuronal activity. Amongst the vast number of 
different methods that are used to render receptors light-sensitive, three strategies involving 
synthetic small molecules have proven particularly useful in our own research (Figure 1).1a 
The simplest and oldest strategy utilizes caged ligands (CLs) (Figure 1, A). These are 
molecules that bear a functional group which is essential for the ligand-receptor interaction, 
but masked with a photolabile protecting group. Upon irradiation, the protecting group is 
cleaved and the active ligand can trigger its biological action. Although CLs have been used 
in neuroscience, they suffer from several disadvantages. Besides potential toxicity issues with 
byproducts arising from the uncaging process (i.e. remnants of the protecting group) and off-
target effects, there is no more external control possible once the caged ligand has been set 
free. Thus, a second, so called photochromic ligand (PCL) approach (Figure 1, B) has 
emerged that is able to overcome some of the latter drawbacks. It employs photoswitchable 
molecules that can change their configuration when irradiated with light of a certain 
wavelength. This configurational change is reversible and since the ligand is typically only 
active in one configuration, the biological effect of the photoswitchable ligand can be 
switched “on” or “off” using light of a certain wavelength. PCLs can be, like other small 
molecule drugs, easily applied and they distribute quickly in tissues. However, if a high 
                                                
1 (a) Fehrentz, T.; Schönberger, M.; Trauner, D. Angew. Chem. Int. Ed. 2011, 50, 12156–12182; (b) Deisseroth, 
K. Nat. Methods 2011, 8, 26–29; (c) Peron, S.; Svoboda, K. Nat. Methods 2011, 8, 30–34; (d) Sjulson, L.; 
Miesenböck, G. Chem. Rev. 2008, 108, 1588–1602; (e) Zhang, F.; Aravanis, A. M.; Adamantidis, A.; de Lecea, 
L.; Deisseroth, K. Nat. Rev. Neurosci. 2007, 8, 577–581.  
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selectivity for a certain receptor subtype and cellular targeting is desired, a third approach, 
named photoswitchable tethered ligand (PTL) approach (Figure 1, C) comes into play. In this 
scenario, the photoswitchable ligand carries a reactive group that allows it to be tethered to 
the target receptor by means of bioconjugation. Since the point of attachment can be a 
cysteine or another reactive amino acid side chain, the PTLs can be genetically encoded. 
Similar to the PCLs, PTLs can be reversibly switched and thus allow for the controlled 
triggering of a biological response.  
 
Figure 1. Three approaches, that provide the basis for optochemical genetics are shown. A) Upon irradiation, the 
caged ligand (CL) breaks apart and is converted into its active form. a) Capsaicin, once uncaged, can stimulate 
TRPV1 channels. B) Photochromic ligands (PCLs) can be reversibly converted into their active or inactive state by 
light. b) 4-GluAzo as an example for a PCL. C) A photoswitchable, thethered ligand (PTL) can selectively be 
attached to a target through bioconjugation and subsequently be activated by light irradiation. c) MAG-1 is a 
typical PTL bearing a maleimide group as a site of attachment.1a 
1.2 The Azobenzene Scaffold 
Azobenzenes have turned out to be an ideal platform for the development of PTLs and PCLs 
in our group.2 This can be attributed to unique features of the azobenzene scaffold. As such, 
azobenzenes can be switched from cis to trans and vice versa when irradiated with light of a 
certain wavelength. This leads to a change in configuration and length and can be used to 
substantially alter the distance between substituents on the aromatic core (Figure 2). They can 
be photoisomerized with light of relatively low intensity since they have high extinction 
coefficients and quantum yields. Their photostability can be attributed to the fact that 
switching of azobenzenes occurs at high rates which prevents intersystem crossing and the 
formation of triplet diradicals, that can in turn react with triplet oxygen to form highly 
reactive and cytotoxic singlet oxygen. Finally, given the rich and established chemistry of 
                                                
2 Banghart, M. R.; Volgraf, M.; Trauner, D. Biochemistry 2006, 45, 15129–15141. 
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azobenzenes, they can be easily synthesized3 and almost all of their properties can be tuned by 
selective functionalization of their core.  
 
Figure 2. Depending on their substitution, azobenzenes can be switched from a trans- to a cis-form by irradiation 
with light of different wavelengths. This cis-form can revert thermally or photochemically to the usually more 
thermodynamically stable trans-form.  
1.3 QAQ 
In recent years, a large number of powerful PTLs and PCLs have been synthesized in our 
group and subsequently used to address fundamental questions in neurobiology. The most 
recently developed PCL was QAQ (quarternary ammonium-azobenzene-quaternary-
ammonium, 3.3), a photoswitch that allows for the optical control of nociception through 
regulation of voltage-gated Na+, Ca2+ and K+ channels.4 To date, the study of nociceptive 
neurons, called nociceptors, has been hampered by the fact that they are inaccessible to 
selective electrophysiological manipulation due to their small central synaptic terminals and 
peripheral sensory endings. Selective silencing of nociceptors was first achieved by delivery 
of QX-314 (3.2)5, a membrane-impermeant derivative of the local anesthetic lidocaine (3.1). 
However, silencing caused by 3.2 is not reversible, which precludes its usefulness for the 
temporally precise control of nociception. To overcome this limitation, QAQ (3.3) was 
developed (Figure 3). This azobenzene, which is flanked on both ends by a quaternary 
ammonium group, can be switched from its elongated trans- to its bent cis-form when 
irradiated with 380-nm light. This configurational change spontaneously reverses in the dark 
or can be triggered in milliseconds upon illumination with 500-nm light. It has been shown 
that QAQ is a potent blocker of voltage-gated ion channels in its trans-form, but not in its cis-
form. It allows for reversible optical silencing of nociceptor activity and was shown to act as a 
light-sensitive analgesic on the cornea of rats, in vivo. 
                                                
3 Hamon, F.; Djedaini-Pilard, F.; Barbot, F.; Len, C. Tetrahedron 2009, 65, 10105–10123. 
4 Mourot, A.; Fehrentz, T.; Le Feuvre, Y.; Smith, C. M.; Herold, C.; Dalkara, D.; Nagy, F.; Trauner, D.; Kramer, 
R. H. Nat. Methods 2012, 9, 396–402. 
5 Binshtok, A. M.; Bean, B. P.; Woolf, C. J. Nature 2007, 449, 607–610. 
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Figure 3. Chemical structures of lidocaine (3.1), QX-314 (3.2) and QAQ (3.3). 
Although QAQ has turned out to be a powerful tool for investigating nociceptors, its 
application could be limited by the fact that switching of trans-QAQ to cis-QAQ requires 
UV-light. The latter is not only harmful to biological systems but also unable to penetrate 
deeper into tissue. We thus targeted QAQ derivatives, which undergo photoswitching upon 
irradiation with longer wavelengths, but still retain their desirable features in altering channel 
activity. Our results towards this goal are presented in the following section.  
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2 Results 
2.1 Published Results 
2.1.1 Exploring the Pharmacology and Action-Spectra of Photochromic 
Open-Channel Blockers 
Publication: Fehrentz, T.6; Kuttruff, C. A.6; Huber, F. M. E.; Kienzler, M.; Mayer, P.; 
Trauner, D. ChemBioChem 2012, 13, 1746–1749. 
 
                                                
6 These authors contributed equally to this work. 
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Abbreviations 
 
°C  degree Celsius 
δ  NMR chemical shift in ppm 
µ  micro 
Ac  Acetyl 
aq.  aqueous 
Boc  tert-Butyloxycarbonyl 
conc.  concentrated 
DMAP  4-(dimethylamino)pyridine 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
equiv  equivalent(s) 
EI  electron impact 
ESI  electron spray ionization 
g  gram 
h  hour(s) 
HRMS  high resolution mass spectroscopy 
Hz  Hertz 
IR  infrared 
J  coupling constant 
M  mol/L 
min  minute(s) 
mL  milliliter 
mmol  millimole 
M.p.  melting point 
NMR  nuclear magnetic resonance 
ppm  parts per million 
Rf  retention factor 
rt  room temperature 
sat.  saturated 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
